Document:

Exhibit 4.1

 Exhibit 4.1 
  
 EXECUTION COPY 
  

  
 CAPITAL ONE MULTI-ASSET EXECUTION TRUST

  
 as Issuer 
  
 and 
  
 THE BANK OF NEW YORK 
  
 as Indenture Trustee 
  
 CLASS A(2003-3) TERMS DOCUMENT 
  
 dated as of August 13, 2003 
  
 to

  
 CARD SERIES INDENTURE SUPPLEMENT 
  
 dated as of October 9, 2002 
  
 to 
  
 ASSET POOL 1 SUPPLEMENT 
  
 dated as of October 9, 2002 
  
 to 
  
 INDENTURE 
  
 dated as of October 9, 2002 
  

  
  

 TABLE OF CONTENTS 
  

	 	  	Page

	
	ARTICLE I
	Definitions and Other Provisions of General Application
			
	 Section 1.01.
	  	Definitions	  	  1
			
	 Section 1.02.
	  	Governing Law	  	  7
			
	 Section 1.03.
	  	Counterparts	  	  7
			
	 Section 1.04.
	  	Ratification of Indenture, the Asset Pool 1 Supplement and Indenture Supplement	  	  7
	
	ARTICLE II
	The Class A(2003-3) Notes
			
	 Section 2.01.
	  	Creation and Designation	  	  8
			
	 Section 2.02.
	  	Adjustments to Required Subordinated Percentages	  	  8
			
	 Section 2.03.
	  	Interest Payment	  	  8
			
	 Section 2.04.
	  	Calculation Agent; Determination of LIBOR	  	  9
			
	 Section 2.05.
	  	Payments of Interest and Principal	  	  9
			
	 Section 2.06.
	  	Form of Delivery of Class A(2003-3) Notes; Depository; Denominations	  	10
			
	 Section 2.07.
	  	Delivery and Payment for the Class A(2003-3) Notes	  	10
			
	 Section 2.08.
	  	Targeted Deposits to the Accumulation Reserve Account	  	10
			
	 Section 2.09.
	  	Capital One Derivative Agreement	  	10
			
	 Section 2.10.
	  	Tax Treatment	  	11

  
  

 -i- 

 THIS CLASS A(2003-3) TERMS DOCUMENT (this “Terms Document”), by and between CAPITAL ONE
MULTI-ASSET EXECUTION TRUST, a statutory trust created under the laws of the State of Delaware (the “Issuer”), having its principal office at E. A. Delle Donne Corporate Center, Montgomery Building, 1011 Centre Road, Wilmington, DE
19805, and THE BANK OF NEW YORK, a New York banking corporation, as Indenture Trustee (the “Indenture Trustee”), is made and entered into as of August 13, 2003. 
  
 Pursuant to this Terms Document, the Issuer shall create a new tranche of Class A Notes and shall specify the principal
terms thereof. 
  
 ARTICLE I 
  
 Definitions and Other Provisions of General Application 
  
 Section 1.01. Definitions. For all purposes of this Terms Document,
except as otherwise expressly provided or unless the context otherwise requires: 
  

	 	(1)	 	the terms defined in this Article have the meanings assigned to them in this Article, and include the plural as well as the singular; 

  

	 	(2)	 	all other terms used herein which are defined in the Indenture Supplement, the Asset Pool 1 Supplement or the Indenture, either directly or by reference therein, have the meanings
assigned to them therein; 

  

	 	(3)	 	all accounting terms not otherwise defined herein have the meanings assigned to them in accordance with generally accepted accounting principles and, except as otherwise herein
expressly provided, the term “generally accepted accounting principles” with respect to any computation required or permitted hereunder means such accounting principles as are generally accepted in the United States of America at the date
of such computation; 

  

	 	(4)	 	all references in this Terms Document to designated “Articles,” “Sections” and other subdivisions are to the designated Articles, Sections and other subdivisions
of this Terms Document; 

  

	 	(5)	 	the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Terms Document as a whole and not to any particular
Article, Section or other subdivision; 

  

	 	(6)	 	in the event that any term or provision contained herein shall conflict with or be inconsistent with any term or provision contained in the Indenture Supplement, the Asset Pool 1
Supplement, the Indenture or the Transfer and Administration Agreement, the terms and provisions of this Terms Document shall be controlling; 

  

	 	(7)	 	each capitalized term defined herein shall relate only to the Class A(2003-3) Notes and no other Tranche of Notes issued by the Issuer; and 

  

 1 

	 	(8)	 	“including” and words of similar import will be deemed to be followed by “without limitation.” 

  
 “Accumulation Period Amount” means $41,666,666.66;
provided, however, if the Accumulation Period Length is determined to be less than twelve (12) months pursuant to Section 3.10(b)(ii) of the Indenture Supplement, the Accumulation Period Amount shall be the amount specified in
the definition of “Accumulation Period Amount” in the Indenture Supplement. 
  
 “Accumulation Reserve Funding Period” shall mean, (a) if the Accumulation Period Length is determined to be one (1) month, there shall be no Accumulation Reserve Funding Period and (b) otherwise, the
period (x) commencing on the earliest to occur of (i) the Monthly Period beginning three (3) calendar months prior to the first Distribution Date for which a budgeted deposit is targeted to be made into the Principal Funding sub-Account of the Class
A(2003-3) Notes pursuant to Section 3.10(b) of the Indenture Supplement, (ii) the Monthly Period following the first Distribution Date following and including the June 2006 Distribution Date for which the Quarterly Excess Spread Percentage is
less than 2%, but in such event the Accumulation Reserve Funding Period shall not be required to commence earlier than 12 months prior to the first Distribution Date for which a budgeted deposit is targeted to be made into the Principal Funding
sub-Account for the Class A(2003-3) Notes pursuant to Section 3.10(b) of the Indenture Supplement, (iii) the Monthly Period following the first Distribution Date following and including the December 2006 Distribution Date for which the
Quarterly Excess Spread Percentage is less than 3%, but in such event the Accumulation Reserve Funding Period shall not be required to commence earlier than 6 months prior to the first Distribution Date for which a budgeted deposit is targeted to be
made into the Principal Funding sub-Account for the Class A(2003-3) Notes pursuant to Section 3.10(b) of the Indenture Supplement, and (iv) the Monthly Period following the first Distribution Date following and including the February 2007
Distribution Date for which the Quarterly Excess Spread Percentage is less than 4%, but in such event the Accumulation Reserve Funding Period shall not be required to commence earlier than 4 months prior to the first Distribution Date for which a
budgeted deposit is targeted to be made into the Principal Funding sub-Account for the Class A(2003-3) Notes pursuant to Section 3.10(b) of the Indenture Supplement and (y) ending on the close of business on the last day of the Monthly Period
preceding the earlier to occur of (i) the Expected Principal Payment Date for the Class A(2003-3) Notes and (ii) the date on which the Class A(2003-3) Notes are paid in full. 
  
 “Asset Pool 1 Supplement” means the Asset Pool 1 Supplement dated as of October 9, 2002, by and between the
Issuer and the Indenture Trustee, as amended and supplemented from time to time. 
  
 “Base Rate” means, with respect to any Monthly Period, the sum of (a) the Card Series Servicing Fee Percentage and (b) the weighted average (based on the Outstanding Dollar Principal Amount of the
related Card Series Notes) of the following: 
  
 (i) in the case of a Tranche of Card Series Dollar Interest-bearing Notes with no Derivative Agreement for interest, the rate of interest applicable to such Tranche for the period from and including the Monthly Interest Accrual Date for
such Tranche of Card Series Dollar Interest-bearing Notes in such Monthly Period to but excluding the Monthly Interest Accrual Date for such Tranche of Card Series Dollar Interest-bearing Notes in the following Monthly Period; 
  

 2 

 (ii) in the case of a Tranche of Card Series Discount Notes, the rate of accretion
(converted to an accrual rate) of such Tranche for the period from and including the Monthly Interest Accrual Date for such Tranche of Card Series Discount Notes in such Monthly Period to but excluding the Monthly Interest Accrual Date for such
Tranche of Card Series Discount Notes in the following Monthly Period; 
  
 (iii) in the case of a Tranche of Card Series Notes with a Performing Derivative Agreement for interest, the rate at which payments by the Issuer to the applicable Derivative Counterparty accrue (prior to the netting
of such payments, if applicable) for the period from and including the Monthly Interest Accrual Date for such Tranche of Card Series Notes in such Monthly Period to but excluding the Monthly Interest Accrual Date for such Tranche of Card Series
Notes in the following Monthly Period; provided, however, that in the case of a Tranche of Card Series Notes with a Performing Derivative Agreement for interest in which the rating on such Tranche of Card Series Notes is not dependant upon the
rating of the applicable Derivative Counterparty, the amount determined pursuant to this clause (iii) will be the higher of (1) the rate determined pursuant to this clause (iii) above and (2) the rate of interest applicable to such Tranche for the
period from and including the Monthly Interest Accrual Date for such Tranche of Card Series Notes in such Monthly Period to but excluding the Monthly Interest Accrual Date for such Tranche of Card Series Notes in the following Monthly Period; and

  
 (iv) in the case of a tranche of Card Series
Notes with a non-Performing Derivative Agreement for interest, the rate specified for that date in the related Terms Document. 
  
 “Calculation Agent” is defined in Section 2.04(a). 
  
 “Class A(2003-3) Adverse Event” means the occurrence of any of the following: (a) an Early Redemption Event
with respect to the Class A(2003-3) Notes or (b) an Event of Default and acceleration of the Class A(2003-3) Notes. 
  
 “Class A(2003-3) Note” means any Note, substantially in the form set forth in Exhibit A-1 to the Indenture Supplement, designated
therein as a Class A(2003-3) Note and duly executed and authenticated in accordance with the Indenture. 
  
 “Class A(2003-3) Noteholder” means a Person in whose name a Class A(2003-3) Note is registered in the Note Register. 
  
 “Class A(2003-3) Termination Date” means the earliest to
occur of (a) the Principal Payment Date on which the Outstanding Dollar Principal Amount of the Class A(2003-3) Notes is paid in full, (b) the Legal Maturity Date and (c) the date on which the Indenture is discharged and satisfied pursuant to
Article VI thereof. 
  
 “Excess Spread
Percentage” shall mean, with respect to any Distribution Date, the amount, if any, by which the Portfolio Yield for the preceding Monthly Period exceeds the Base Rate for such Monthly Period. 
  

 3 

 “Expected Principal Payment Date” means July 15, 2008. 
  
 “Initial Dollar Principal Amount” means $500,000,000.

  
 “Indenture” means the Indenture dated as of
October 9, 2002, by and between the Issuer and the Indenture Trustee, as amended and supplemented from time to time. 
  
 “Indenture Supplement” means the Card Series Indenture Supplement dated as of October 9, 2002, by and between the Issuer and the
Indenture Trustee, as amended and supplemented from time to time. 
  
 “Interest Payment Date” means the fifteenth day of each month commencing in September 2003, or if such fifteenth day is not a Business Day, the next succeeding Business Day. 
  
 “Interest Period” means, with respect to any Interest
Payment Date, the period from and including the previous Interest Payment Date (or in the case of the initial Interest Payment Date, from and including the Issuance Date) through the day preceding such Interest Payment Date. 
  
 “Issuance Date” means August 13, 2003. 
  
 “Legal Maturity Date” means May 16, 2011. 
  
 “LIBOR” means, for any Interest Period, the London interbank
offered rate for one-month United States dollar deposits determined by the Indenture Trustee on the LIBOR Determination Date for each Interest Period in accordance with the provisions of Section 2.04. 
  
 “LIBOR Determination Date” means August 11, 2003 for the
period from and including the Issuance Date to but excluding September 15, 2003 and the second London Business Day prior to the commencement of the second and each subsequent Interest Period. 
  
 “London Business Day” means any Business Day on which
dealings in deposits in United States Dollars are transacted in the London interbank market. 
  
 “Maximum Subordination Amount of Class B Notes” means, for the Class A(2003-3) Notes for any date of determination, an amount equal to the product of (a) Adjusted Outstanding Dollar Principal Amount
of the Class A(2003-3) Notes on such date of determination and (b) the percentage equivalent of a fraction, the numerator of which is 10 and the denominator of which is 81.25. 
  
 “Note Interest Rate” means a rate per annum equal to 0.25% in excess of LIBOR as determined by the
Calculation Agent on the related LIBOR Determination Date with respect to each Interest Period. 
  
 “Paying Agent” means The Bank of New York. 
  
 “Portfolio Yield” means, with respect to any Monthly Period, the annualized percentage equivalent of a fraction: 
  

 4 

 (a) the numerator of which is equal to the sum of: 
  
 (i) the aggregate amount of Finance Charge Amounts allocated
to the Card Series with respect to such Monthly Period; plus 
  
 (ii) the aggregate amount of Interest Funding sub-Account Earnings on all Tranches of Card Series Notes for such Monthly Period; plus 
  
 (iii) any amounts to be treated as Card Series Finance Charge Amounts pursuant to Sections 3.20(d)
and 3.27(a) of the Indenture Supplement; minus 
  
 (iv) the excess, if any, of (1) the sum of the PFA Prefunding Earnings Shortfall plus the PFA Accumulation Earnings Shortfall over (2) the sum of the aggregate amount to be treated as Card Series Finance Charge
Amounts for such Monthly Period pursuant to Sections 3.04(a)(ii) and 3.25(a) of the Indenture Supplement plus any other amounts applied to cover earnings shortfalls on amounts in the Principal Funding sub-Account for any tranche
of Card Series Notes for such Monthly Period; minus 
  
 (v) the Card Series Default Amount for such Monthly Period; and 
  
 (b) the denominator of which is the numerator used in the calculation of the Card Series Floating Allocation Percentage for such Monthly Period.

  
 “Quarterly Excess Spread Percentage” means,
with respect to the December 2003 Distribution Date and each Distribution Date thereafter, the percentage equivalent of a fraction the numerator of which is the sum of the Excess Spread Percentages with respect to the immediately preceding three
Monthly Periods and the denominator of which is three. 
  
 “Record Date” means, for any Distribution Date, the last Business Day of the preceding Monthly Period. 
  
 “Reference Banks” means four major banks in the London interbank market selected by the Beneficiary. 
  
 “Required Accumulation Reserve sub-Account Amount” means,
with respect to any Monthly Period during the Accumulation Reserve Funding Period, an amount equal to (i) 0.5% of the Outstanding Dollar Principal Amount of the Class A(2003-3) Notes as of the close of business on the last day of the preceding
Monthly Period or (ii) any other amount designated by the Issuer; provided, however, that if such designation is of a lesser amount, the Note Rating Agencies shall have provided prior written confirmation that a Ratings Effect will not
occur with respect to such change. 
  
 “Required
Subordinated Amount of Class B Notes” means, for the Class A(2003-3) Notes for any date of determination, an amount equal to the product of (a) the Required Subordinated Percentage of Class B Notes for such Class A(2003-3) Notes on such
date of determination and (b) the Adjusted Outstanding Dollar Principal Amount of such Class A(2003-3) Notes on such date of determination; provided, however, that such an amount shall not exceed the 
  

 5 

 Maximum Subordination Amount of Class B Notes for the Class A(2003-3) Notes; provided further,
however, that for any date of determination on or after the occurrence and during the continuation of a Class A(2003-3) Adverse Event, the Required Subordinated Amount of Class B Notes for the Class A(2003-3) Notes will be the greater of (x)
the amount determined above for such date of determination and (y) the amount determined above for the date immediately prior to the date on which such Class A(2003-3) Adverse Event shall have occurred. 
  
 “Required Subordinated Amount of Class C Notes” means, for
the Class A(2003-3) Notes for any date of determination, an amount equal to the product of (a) the Required Subordinated Percentage of Class C Notes for such Class A(2003-3) Notes on such date of determination and (b) the Adjusted Outstanding Dollar
Principal Amount of such Class A(2003-3) Notes on such date of determination; provided, however, that for any date of determination, unless (i) the Prefunding Target Amount for any Tranche of Card Series Notes on such date of
determination is greater than zero or (ii) any prefunded amounts are on deposit in a Principal Funding sub-Account on such date of determination for any Tranche of Card Series Notes, the Required Subordinated Amount of Class C Notes for the Class
A(2003-3) Notes will not be less than an amount equal to (i) 3.0% of the Initial Dollar Principal Amount of the Class A(2003-3) Notes, minus (ii) the Required Subordinated Amount of Class D Notes for the Class A(2003-3) Notes; provided
further, however, that for any date of determination on or after the occurrence and during the continuation of a Class A(2003-3) Adverse Event, the Required Subordinated Amount of Class C Notes for the Class A(2003-3) Notes will be the
greater of (x) the amount determined above for such date of determination, (y) the amount determined above for the date immediately prior to the date on which such Class A(2003-3) Adverse Event shall have occurred and (z) unless (i) the
Prefunding Target Amount for any Tranche of Card Series Notes on such date of determination is greater than zero or (ii) any prefunded amounts are on deposit in a Principal Funding sub-Account on such date of determination for any Tranche of Card
Series Notes, the amount determined pursuant to the preceding proviso. 
  
 “Required Subordinated Amount of Class D Notes” means, for the Class A(2003-3) Notes for any date of determination, an amount equal to the product of (a) the Required Subordinated Percentage of Class D Notes for such Class
A(2003-3) Notes on such date of determination and (b) the Adjusted Outstanding Dollar Principal Amount of such Class A(2003-3) Notes on such date of determination; provided, however, that for any date of determination, unless (i) the
Prefunding Target Amount for any Tranche of Card Series Notes on such date of determination is greater than zero or (ii) any prefunded amounts are on deposit in a Principal Funding sub-Account on such date of determination for any Tranche of Card
Series Notes, the Required Subordinated Amount of Class D Notes for the Class A(2003-3) Notes will not be less than an amount equal to 1.8462% of the Initial Dollar Principal Amount of the Class A(2003-3) Notes, provided further,
however, that for any date of determination on or after the occurrence and during the continuation of a Class A(2003-3) Adverse Event, the Required Subordinated Amount of Class D Notes for the Class A(2003-3) Notes will be the greatest of (x)
the amount determined above for such date of determination, (y) the amount determined above for the date immediately prior to the date on which such Class A(2003-3) Adverse Event shall have occurred and (z) unless (i) the Prefunding Target Amount
for any Tranche of Card Series Notes on such date of determination is greater than zero or (ii) any prefunded amounts are on deposit in a Principal Funding sub-Account on such date of determination for any Tranche of Card Series Notes, the amount
determined pursuant to the preceding proviso. 
  

 6 

 “Required Subordinated Percentage of Class B Notes” means, for the Class A(2003-3)
Notes, 12.3077%, subject to adjustment in accordance with Section 2.02. 
  
 “Required Subordinated Percentage of Class C Notes” means, for the Class A(2003-3) Notes, 8.9231%, subject to adjustment in accordance with Section 2.02. 
  
 “Required Subordinated Percentage of Class D Notes” means,
for the Class A(2003-3) Notes, 1.8462%, subject to adjustment in accordance with Section 2.02. 
  
 “Stated Principal Amount” means $500,000,000. 
  
 “Telerate Page 3750” means the display page currently so designated on the Moneyline Telerate Service (or such other page as may replace
that page on that service for the purpose of displaying comparable rates or prices). 
  
 Section 1.02. Governing Law. THIS TERMS DOCUMENT WILL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK, INCLUDING SECTION 5-1401 OF THE GENERAL OBLIGATION LAW, WITHOUT REFERENCE
TO ITS CONFLICT OF LAW PROVISIONS AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS. 
  
 Section 1.03. Counterparts. This Terms Document may be executed in any number of counterparts, each of which so executed will be deemed to be an
original, but all such counterparts will together constitute but one and the same instrument. 
  
 Section 1.04. Ratification of Indenture, the Asset Pool 1 Supplement and Indenture Supplement. As supplemented by this Terms Document, each of the Indenture, the Asset Pool 1 Supplement and the Indenture
Supplement is in all respects ratified and confirmed and the Indenture as so supplemented by the Asset Pool 1 Supplement as so supplemented by the Indenture Supplement as so supplemented and this Terms Document shall be read, taken and construed as
one and the same instrument. 
  
 [END OF ARTICLE I] 
  
  

 7 

 ARTICLE II 
  
 The Class A(2003-3) Notes 
  
 Section 2.01. Creation and Designation. There is hereby created a tranche of Card Series Class A Notes to be issued pursuant to the Indenture, the
Asset Pool 1 Supplement and the Indenture Supplement to be known as the “Card Series Class A(2003-3) Notes.” 
  
 Section 2.02. Adjustments to Required Subordinated Percentages. 
  
 (a) On any date, the Issuer may change the Required Subordinated Percentage of Class B Notes or the Required Subordinated
Percentage of Class C Notes, in each case for the Class A(2003-3) Notes, without the consent of any Noteholders or any Note Rating Agencies, provided that, after giving effect to such change, (x) the sum of the Required Subordination Percentage of
Class B Notes and the Required Subordinated Percentage of Class C Notes, in each case, for the Class A(2003-3) Notes after giving effect to such change is equal to or greater than the sum of the Required Subordination Percentage of Class B Notes and
the Required Subordinated Percentage of Class C Notes, in each case, for the Class A(2003-3) Notes immediately prior to giving effect to such change and (y) the Required Subordinated Amount of Class B Notes for the Class A(2003-3) Notes does not
exceed the Maximum Subordinated Amount of Class B Notes. 
  
 (b)
On any date, the Issuer may change the Required Subordinated Percentage of Class B Notes, the Required Subordinated Percentage of Class C Notes or the Required Subordinated Percentage of Class D Notes, in each case for the Class A(2003-3) Notes,
such that after giving effect to all changes to such percentages on such date the sum of the Required Subordination Percentage of Class B Notes, the Required Subordinated Percentage of Class C Notes and the Required Subordinated Amount of Class D
Notes, in each case, for the Class A(2003-3) Notes after giving effect to such change is less than the sum of the Required Subordination Percentage of Class B Notes, the Required Subordinated Percentage of Class C Notes and the Required Subordinated
Amount of Class D Notes, in each case, for the Class A(2003-3) Notes immediately prior to giving effect to such change, without the consent of any Noteholders, provided that the Issuer has (i) received written confirmation from each Note Rating
Agency that has rated any Outstanding Notes of the Card Series that the change in such percentage will not result in a Ratings Effect with respect to any Outstanding Class A(2003-3) Notes and (ii) delivered to the Indenture Trustee and the Note
Rating Agencies a Master Trust Tax Opinion for each Master Trust and an Issuer Tax Opinion. 
  
 Section 2.03. Interest Payment. 
  
 (a) For each Interest Payment Date, the amount of interest due with respect to the Class A(2003-3) Notes shall be an amount equal to the product of (i)(A) a fraction, the numerator of which is the actual number of days in the related
Interest Period and the denominator of which is 360, times (B) the Note Interest Rate in effect with respect to the related Interest Period, times (ii) the Outstanding Dollar Principal Amount of the Class A(2003-3) Notes determined as
of the Record Date preceding the related Distribution Date. Any interest on the Class A(2003-3) Notes will be calculated on the basis of the actual number of days in the related Interest Period and a 360-day year. 
  

 8 

 (b) Pursuant to Section 3.03 of the Indenture Supplement, on each Distribution Date, the Indenture
Trustee shall deposit into the Class A(2003-3) Interest Funding sub-Account the portion of Card Series Available Finance Charge Amounts allocable to the Class A(2003-3) Notes. 
  
 Section 2.04. Calculation Agent; Determination of LIBOR. 
  
 (a) The Issuer hereby agrees that for so long as any Class A(2003-3) Notes
are Outstanding, there shall at all times be an agent appointed to calculate LIBOR for each Interest Period (the “Calculation Agent”). The Issuer hereby initially appoints the Indenture Trustee as the Calculation Agent for purposes
of determining LIBOR for each Interest Period. The Calculation Agent may be removed by the Issuer at any time. If the Calculation Agent is unable or unwilling to act as such or is removed by the Issuer, or if the Calculation Agent fails to determine
LIBOR for an Interest Period, the Issuer shall promptly appoint a replacement Calculation Agent that does not control or is not controlled by or under common control with the Issuer or its Affiliates. The Calculation Agent may not resign its duties,
and the Issuer may not remove the Calculation Agent, without a successor having been duly appointed. 
  
 (b) On each LIBOR Determination Date, the Calculation Agent shall determine LIBOR on the basis of the rate for deposits in United States dollars for a
one-month period which appears on Telerate Page 3750 as of 11:00 a.m., London time, on such date. If such rate does not appear on Telerate Page 3750, the rate for that LIBOR Determination Date shall be determined on the basis of the rates at which
deposits in United States dollars are offered by the Reference Banks at approximately 11:00 a.m., London time, on that day to prime banks in the London interbank market for a one-month period. The Calculation Agent shall request the principal London
office of each of the Reference Banks to provide a quotation of its rate. If at least two such quotations are provided, the rate for that LIBOR Determination Date shall be the arithmetic mean of the quotations. If fewer than two quotations are
provided as requested, the rate for that LIBOR Determination Date will be the arithmetic mean of the rates quoted by major banks in New York City, selected by the Beneficiary, at approximately 11:00 a.m., New York City time, on that day for loans in
United States dollars to leading European banks for a one-month period. 
  
 (c) The Note Interest Rate applicable to the then current and the immediately preceding Interest Periods may be obtained by telephoning the Indenture Trustee at its corporate trust office at (212) 815-3247 or such other telephone number as
shall be designated by the Indenture Trustee for such purpose by prior written notice by the Indenture Trustee to each Noteholder from time to time. 
  
 (d) On each LIBOR Determination Date, the Calculation Agent shall send to the Indenture Trustee, the Issuer and the Beneficiary, by facsimile
transmission, notification of LIBOR for the following Interest Period. 
  
 Section 2.05. Payments of Interest and Principal. 
  
 (a) Any installment of interest or principal, if any, payable on any Class A(2003-3) Note which is punctually paid or duly provided for by the Issuer and the Indenture Trustee on the applicable Interest Payment Date or Principal Payment
Date shall be paid by the Paying Agent to the Person in whose name such Class A(2003-3) Note (or one or more Predecessor Notes) is registered on the Record Date, by wire transfer of immediately available funds to such Person’s 
  

 9 

 account as has been designated by written instructions received by the Paying Agent from such Person not later than the
close of business on the third Business Day preceding the date of payment or, if no such account has been so designated, by check mailed first-class, postage prepaid to such Person’s address as it appears on the Note Register on such Record
Date, except that with respect to Notes registered on the Record Date in the name of the nominee of Cede & Co., payment shall be made by wire transfer in immediately available funds to the account designated by such nominee. 
  
 (b) The right of the Class A(2003-3) Noteholders to receive payments from the
Issuer will terminate on the first Business Day following the Class A(2003-3) Termination Date. 
  
 Section 2.06. Form of Delivery of Class A(2003-3) Notes; Depository; Denominations. 
  
 (a) The Class A(2003-3) Notes shall be delivered in the form of a global Registered Note as provided in Sections 202
and 301(i) of the Indenture, respectively. 
  
 (b) The
Depository for the Class A(2003-3) Notes shall be The Depository Trust Company, and the Class A(2003-3) Notes shall initially be registered in the name of Cede & Co., its nominee. 
  
 (c) The Class A(2003-3) Notes will be issued in minimum denominations of $1,000 and integral multiples of that amount.

  
 Section 2.07. Delivery and Payment for the Class A(2003-3)
Notes. The Issuer shall execute and deliver the Class A(2003-3) Notes to the Indenture Trustee for authentication, and the Indenture Trustee shall deliver the Class A(2003-3) Notes when authenticated, each in accordance with Section 303
of the Indenture. 
  
 Section 2.08. Targeted Deposits to the
Accumulation Reserve Account. 
  
 The deposit targeted to be
made to the Accumulation Reserve Account for any Monthly Period during the Accumulation Reserve Funding Period will be an amount equal to the Required Accumulation Reserve sub-Account Amount. 
  
 Section 2.09. Capital One Derivative Agreement. 
  
 (a) On any Distribution Date, any amount owed by the Issuer pursuant to the
ISDA Master Agreement, dated as of October 9, 2002, as supplemented by the Schedule thereto, dated as of October 9, 2002, and the Confirmation thereto relating to the Class A(2003-3) Notes, dated as of August 13, 2003 (collectively, the
“Capital One Derivative Agreement”), each between Capital One Bank and the Issuer, shall be paid to Capital One Bank from Card Series Finance Charge Amounts (available after giving effect to Sections 3.01(a) through
(l) of the Indenture Supplement) for such Distribution Date in an amount not to exceed the lesser of (i) the product of (x) the amount of Card Series Finance Charge Amounts available for application pursuant to Section 3.01(m) of the
Indenture Supplement times (y) a fraction, the numerator of which is the Nominal Liquidation Amount of the Class A(2003-3) Notes as of the close of business on the last day of the preceding Monthly Period and the denominator of which is the
Nominal Liquidation Amount of all tranches of Card Series Notes as of the close of business on the last day of the preceding Monthly 
  

 10 

 Period and (ii) the amount of such payment owed by the Issuer to Capital One Bank on such Distribution Date. 

 
 (b) On any Distribution Date, any amount owed to the Issuer pursuant to
the Capital One Derivative Agreement shall be, when received by the Issuer, treated as Card Series Finance Charge Amounts for the purposes of Section 3.01(n) of the Indenture Supplement. 
  
 (c) The Capital One Derivative Agreement shall not be considered a
“Derivative Agreement” (as such term is defined in the Indenture) for the purposes of Indenture, the Asset Pool Supplement or the Indenture Supplement. 
  
 Section 2.10. Tax Treatment. Notwithstanding any other express or implied agreement to the contrary, each of the
Issuer and the Class A(2003-3) Noteholders are hereby deemed to agree that they and any recipient of the Prospectus Supplement dated August 6, 2003 and the Prospectus dated July 28, 2003, each relating to the Class A(2003-3) Notes (or their
employees, representatives, or other agents), may disclose to any and all persons, without limitation of any kind, the Tax Treatment and Tax Structure of any transaction relating to the Issuer or the Class A(2003-3) Notes and all materials of any
kind (including opinions or other tax analyses) that are provided to any of them relating to such Tax Treatment and Tax Structure. For purposes of this Section 2.10, “Tax Treatment” refers to the purported or claimed treatment of
the Issuer and the Class A(2003-3) Notes under the Internal Revenue Code, and “Tax Structure” refers to any fact that may be relevant to understanding such Tax Treatment. It is hereby confirmed that each of the foregoing have been
deemed to so agree since the commencement of discussions regarding the Class A(2003-3) Notes. 
  
 [END OF ARTICLE II] 
  

 11 

 IN WITNESS WHEREOF, the parties hereto have caused this Terms Document to be duly executed, all as of the
day and year first above written. 
  

	
	CAPITAL ONE MULTI-ASSET EXECUTION TRUST, by DEUTSCHE
BANK TRUST COMPANY DELAWARE, not in its individual capacity, but solely as Owner Trustee on behalf of the Trust
		
	 By:
	 	 /s/    JENNA KAUFMAN

	Name:	 	Jenna Kaufman
	Title:	 	Attorney-in-fact

  

	
	THE BANK OF NEW YORK, as Indenture Trustee and not in its individual capacity
		
	 By:
	 	 /s/    ALLISON R. CLAN

	Name:	 	Allison R. Clan
	Title:	 	Assistant Treasurer

  
 [Signature Page
to the Class A(2003-3) Terms Document] 
  

 12<PAGE>

                             [LOGO] Protein Polymer
                                  TECHNOLOGIES

           ----------------------------------------------------------

                                    SERIES I

                              AMENDED AND RESTATED
                               SECURITIES PURCHASE
                                    AGREEMENT

           ----------------------------------------------------------

                                  May 12, 2003

<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                                         Page
                                                                                                         ----
         <S>                                                                                             <C>
1.       DEFINITIONS...................................................................................     1

2.       AUTHORIZATION OF SECURITIES...................................................................     4

3.       SALE AND PURCHASE OF PREFERRED STOCK AND WARRANTS.............................................     5

4.       REGISTER OF SECURITIES; RESTRICTIONS ON TRANSFER OF SECURITIES; REMOVAL OF RESTRICTIONS ON
         TRANSFER OF SECURITIES........................................................................     6

         4.1      Register of Securities...............................................................     6

         4.2      Restrictions on Transfer.............................................................     6

         4.3      Removal of Transfer Restrictions.....................................................     9

5.       REPRESENTATIONS AND WARRANTIES BY AND COVENANTS OF THE COMPANY................................    10

         5.1      Organization, Standing, etc..........................................................    10

         5.2      Certificate of Incorporation and Bylaws..............................................    10

         5.3      Subsidiaries.........................................................................    10

         5.4      Qualification........................................................................    10

         5.5      Capital Stock........................................................................    10

         5.6      Corporate Acts and Proceedings.......................................................    12

         5.7      Compliance with Other Instruments....................................................    12

         5.8      Binding Obligations..................................................................    13

         5.9      Securities Laws......................................................................    13

         5.10     Financial Statements.................................................................    13

         5.11     Changes..............................................................................    14

         5.12     Material Agreements of the Company...................................................    14

         5.13     Litigation...........................................................................    14

         5.14     Brokers or Finders...................................................................    15

         5.15     Disclosure...........................................................................    15

         5.16     Intellectual Property................................................................    15

         5.17     Retirement Obligations...............................................................    15

         5.18     No Governmental Consent or Approval Required.........................................    15

         5.19     Registration.........................................................................    16

         5.20     Reporting Status.....................................................................    16
</TABLE>

                                       -i-

<PAGE>

                                TABLE OF CONTENTS
                                   (continued)

<TABLE>
<CAPTION>
                                                                                                        Page
                                                                                                        ----
         <S>                                                                                            <C>
         5.21     Title to Property and Assets.........................................................   16

         5.22     Environmental and Safety Laws........................................................   16

         5.23     Absence of Undisclosed Liabilities...................................................   17

         5.24     Permits..............................................................................   17

         5.25     Investment Company...................................................................   17

         5.26     Market Manipulation..................................................................   17

         5.27     Form S-2.............................................................................   17

         5.28     Registration Rights..................................................................   17

         5.29     Acquisition..........................................................................   17

         5.30     Independent Accountants..............................................................   17

         5.31     Significant Customers and Suppliers..................................................   18

         5.32     Sarbanes-Oxley Act...................................................................   18

6.       CONDITIONS OF PARTIES' OBLIGATIONS............................................................   18

         6.1      Conditions of Investors' Obligations at the Closing..................................   18

         6.2      Conditions of Company's Obligations..................................................   20

7.       [INTENTIONALLY OMITTED.]......................................................................   20

8.       [INTENTIONALLY OMITTED.]......................................................................   20

9.       REGISTRATION OF RESTRICTED STOCK..............................................................   20

         9.1      Required Registration................................................................   20

         9.2      Registration Procedures..............................................................   21

         9.3      Expenses.............................................................................   22

         9.4      Delay in Filing of Registration Statement............................................   22

         9.5      Indemnification......................................................................   23

         9.6      Reporting Requirements Under the Exchange Act........................................   26

         9.7      Stockholder Information..............................................................   26

10.      MISCELLANEOUS.................................................................................   26

         10.1     Waivers and Amendments...............................................................   26

         10.2     Effect of Waiver or Amendment........................................................   26

         10.3     Rights of Holders Inter Se...........................................................   26

         10.4     Exculpation Among Investors and Holders..............................................   27
</TABLE>

                                      -ii-

<PAGE>

                                TABLE OF CONTENTS
                                   (continued)

<TABLE>
<CAPTION>
                                                                                                        Page
                                                                                                        ----
         <S>                                                                                            <C>
         10.5     Brokers or Finders...................................................................   27

         10.6     Notices..............................................................................   27

         10.7     Entire Agreement.....................................................................   28

         10.8     Severability.........................................................................   28

         10.9     Parties in Interest..................................................................   28

         10.10    Headings.............................................................................   28

         10.11    Choice of Law........................................................................   28

         10.12    Expenses.............................................................................   28

         10.13    Counterparts.........................................................................   29

         10.14    Publicity............................................................................   29

         10.15    Same Terms and Price.................................................................   29

         10.16    Covenant to Issue Instruments or Certificates........................................   29
</TABLE>

ANNEXES

         A      -      Schedule of Investors and Required Payment
         B      -      Certificate of Designation of Series I Preferred Stock
         C      -      Form of First Warrant
         D      -      Form of Second Warrant
         E      -      Risk Factors
         F      -      Schedule of Exceptions and Disclosure Schedule
         G      -      Form of Legal Opinion
         H      -      Form of Press Release

                                      -iii-

<PAGE>

                                                                    EXHIBIT 10.1

                                    SERIES I

               AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT

     THIS SECURITIES PURCHASE AGREEMENT (this "Agreement") is entered into as of
May 12, 2003 among Protein Polymer Technologies, Inc., a Delaware corporation
(the "Company"), and the other Persons listed on Annex A hereto (sometimes
referred to herein individually as "Investor" and sometimes collectively as
"Investors").

     1. Definitions. Unless the context otherwise requires, the terms defined in
this Section 1 shall have the meanings herein specified for all purposes of this
Agreement, applicable to both the singular and plural forms of any of the terms
herein defined. All accounting terms defined in this Section 1 and those
accounting terms used in this Agreement not defined in this Section 1 shall,
except as otherwise provided for herein, be construed in accordance with those
generally accepted accounting principles that the Company is required to employ
by the terms of this Agreement. If and so long as the Company has any
Subsidiary, unless otherwise noted herein, the accounting terms defined in this
Section 1 and those accounting terms appearing in this Agreement but not defined
in this Section 1 shall be determined on a consolidated basis for the Company
and each of its Subsidiaries, and the financial statements and other financial
information to be furnished by the Company pursuant to this Agreement shall be
consolidated.

          "2001 Annual Report" shall mean the Company's Report on Form 10-KSB
for the fiscal year ended December 31, 2001.

          "Action" shall mean any action, suit, arbitration or other legal,
administrative or other proceeding or investigation pending by or before any
court, arbitrator or Governmental Entity.

          "Agreement" shall mean this Securities Purchase Agreement.

          "Balance Sheet" and "Balance Sheet Date" shall have the meaning
assigned to such terms in Section 5.10 hereof.

          "Board" shall mean the Board of Directors of the Company.

          "California Securities Law" shall mean the California Corporate
Securities Law of 1968, as amended.

          "Certificate" shall have the meaning assigned to it in Section 2
hereof.

<PAGE>

          "Common Stock" shall mean the Company's common stock, par value $0.01
per share.

          "Commission" shall mean the Securities and Exchange Commission.

          "Company" shall have the meaning assigned to it in the introductory
paragraph of this Agreement.

          "Conversion Stock" shall have the meaning assigned to it in Section 2
hereof.

          "Equity Security" shall mean the Common Stock, or any security
convertible into the Common Stock, or any security carrying any warrant or right
to subscribe to or purchase the Common Stock or any security convertible into
the Common Stock, or any such warrant or right.

          "First Warrants" shall have the meaning assigned to such term in
Section 2 hereof.

          "First Warrant Stock" shall have the meaning assigned to such term in
Section 2 hereof.

          "Form 10-QSB" shall mean the Company's Quarterly Report on Form 10-QSB
for the quarterly period ended September 30, 2002.

          "Governmental Entity" shall mean any federal, state, local or foreign
governmental authority, bureau, commission, board, agency or instrumentality.

          "Holder" of any security shall mean the record or beneficial owner of
such security. A Holder of Preferred Stock shall be treated as the Holder of the
Conversion Stock underlying the Preferred Stock and a Holder of a Warrant shall
be treated as the Holder of the Warrant Stock underlying the Warrant.

          "Holders of a Majority of the Preferred Stock" shall mean, on a given
date, the Person or Persons who are the Holders of greater than 50% of the
outstanding Preferred Stock.

          "Initial Closing" and "Initial Closing Date" shall have the meanings
assigned to such terms in Section 3(c) hereof.

          "Investor" shall have the meaning assigned to it in the introductory
paragraph of this Agreement.

                                        2

<PAGE>

          "Material Adverse Effect" shall mean a material and adverse effect on
the business, assets, property, operations, results of operations, business
prospects, or financial condition of the Company.

          "Offering Memorandum" shall mean the Confidential Private Placement
Materials of the Company dated September 2002.

          "Person" shall mean any natural person, corporation, trust,
association, company, partnership, joint venture, joint stock company,
unincorporated organization and other entity and any government entity (or any
department thereof), governmental agency, instrumentality or political
subdivision.

          "Preferred Stock" shall have the meaning assigned to it in Section 2
hereof.

          "Required Initial Payment" shall mean, with respect to each Investor,
the number of shares of Preferred Stock purchased by such Investor at the
Initial Closing, multiplied by $100.00, as set forth on Annex A hereto.

          "Restricted Stock" means (i) the Common Stock issued or issuable to
the Investors upon conversion of the Preferred Stock issued and sold pursuant to
this Agreement or upon exercise of the Warrants and (ii) any Common Stock issued
or issuable (either directly or upon the conversion or exercise of any warrant,
right, or other security) with respect to the Common Stock referred to in clause
(i) above by way of a stock dividend or stock split or in connection with a
combination of shares, reclassification, recapitalization, merger or
consolidation or reorganization; provided, however, that such shares of Common
Stock shall only be treated as Restricted Stock if and so long as they have not
been (x) sold to or through a broker or dealer or underwriter in a public
distribution or a public securities transaction, or (y) sold in a transaction
exempt from the registration and prospectus delivery requirements of the
Securities Act under Section 4(1) thereof so that all transfer restrictions and
restrictive legends with respect to such Common Stock are removed upon the
consummation of such sale and the Company receives an opinion of counsel for the
Company (with a copy to the seller of such Common Stock), which shall be in form
and content reasonably satisfactory to the Company, to the effect that such
Common Stock in the hands of the purchaser is freely transferable without
restriction or registration under the Securities Act in any public or private
transaction.

          "Rule 144" shall mean Rule 144 of the Commission under the Securities
Act.

          "Second Warrants" shall have the meaning assigned to such term in
Section 2 hereof.

                                        3

<PAGE>

          "Second Warrant Stock" shall have the meaning assigned to such term is
Section 2 hereof.

          "Securities" shall have the meaning assigned to it in Section 2
hereof.

          "Securities Act" shall mean the Securities Act of 1933, as amended.

          "Stock Plans" shall mean the Company's 1989 Stock Option Plan, 1992
Stock Option Plan, 1996 Non-Employee Directors' Stock Option Plan, 2002 Stock
Option Plan and Employee Stock Purchase Plan, collectively.

          "Subscription Deposit" shall mean, with respect to each Investor in a
Subsequent Subscription, the number of shares of Preferred Stock subscribed for
to be purchased by such Investor at a Subsequent Subscription, multiplied by
$100.00, as set forth on Annex A-2 hereto.

          "Subsequent Subscription" and "Subsequent Subscription Date" shall
have the meanings assigned to such terms in Section 3(d) hereof.

          "Subsidiary" shall mean any Person, at least 50% of the outstanding
stock of which is at the time owned or controlled directly or indirectly by the
Company or by one or more of such subsidiary entities or both, or has the power
to vote or direct the voting of sufficient securities to elect a majority of the
board of directors.

          "Suspension Period" shall have the meaning assigned to it in Section
9.1(b) hereof.

          "Warrants" shall mean the First Warrants and Second Warrants,
collectively.

          "Warrant Stock" shall mean the First Warrant Stock and Second Warrant
Stock, collectively.

     2. Authorization of Securities. The Company has authorized the issue and
sale of up to (i) 100,000 shares of its Series I Convertible Preferred Stock,
par value $0.01 per share (the "Preferred Stock"), having the rights,
preferences and privileges set forth in the Certificate of Designation attached
hereto as Annex B (hereinafter referred to as the "Certificate"), (ii) warrants,
having terms and conditions in the form of Warrant attached hereto as Annex C
(collectively, the "First Warrants"), to purchase up to an aggregate of
2,727,272 shares of Common Stock (the "First Warrant Stock") and (iii) warrants,
having terms and conditions in the form of Warrant attached hereto as Annex D
(collectively, the "Second Warrants"), to purchase up to an aggregate of
1,818,181 shares of Common Stock (the "Second Warrant Stock"). The Common

                                        4

<PAGE>

Stock into which the Preferred Stock is convertible is sometimes referred to
herein as the "Conversion Stock"; and the Preferred Stock, the Warrants, the
Warrant Stock and the Conversion Stock are sometimes referred to herein
individually and collectively as the "Securities."

     3. Sale and Purchase of Preferred Stock and Warrants.

        (a) Upon the terms and subject to the conditions herein contained, the
Company agrees to sell to each Investor, and each Investor severally agrees to
purchase from the Company, at the Initial Closing on the Initial Closing Date,
(i) the number of shares of Preferred Stock, and (ii) the First Warrants and the
Second Warrants to purchase the number of shares of First Warrant Stock and
Second Warrant Stock, in each case as set forth opposite its name on Annex A
hereto with respect to the Initial Closing, and each Investor shall pay to the
Company the Required Initial Payment.

        (b) [Intentionally omitted.]

        (c) The initial closing of the sale to and purchase by the Investors of
the Preferred Stock and Warrants pursuant to Section 3(a) hereof (the "Initial
Closing") shall occur at the offices of Paul, Hastings, Janofsky & Walker LLP,
515 South Flower Street, Los Angeles, California, at the hour of 10 o'clock
A.M., California time, on March 11, 2003 or at such different time or day as the
Investors and the Company shall agree (the "Initial Closing Date"). At the
Initial Closing, the Company will deliver to each Investor instruments or
certificates evidencing the Securities being purchased by each Investor, each of
which shall be registered in such Investor's name as stated on Annex A hereto
with respect to the Initial Closing, against delivery to the Company of payment
by cashier's check or wire transfer, or such other form acceptable to the
Company, in an amount equal to the Required Initial Payment of such Investor.

        (d) After the Initial Closing, additional shares of Preferred Stock
(which, together with the Preferred Stock issued at the Initial Closing, shall
not exceed 100,000 shares in the aggregate), additional First Warrants (which,
together with the First Warrants issued at the Initial Closing, shall not
represent the right to acquire more than 2,727,272 shares of First Warrant Stock
in the aggregate) and additional Second Warrants (which together with the Second
Warrants issued at the Initial Closing, shall not represent the right to acquire
more than 1,818,181 shares of Second Warrant Stock in the aggregate), may be
subscribed for, subject only to the fulfillment of the conditions set forth in
clause (i) of Section 3(f), at one or more Subsequent Subscriptions (each a
"Subsequent Subscription") on or before May 12, 2003. Each Subsequent
Subscription shall be effective upon the date (a "Subsequent Subscription Date")
of the Company's receipt from an Investor of a cashier's check or wire transfer
funds in the amount of such Investor's Subscription Deposit and the applicable
Investor having entered into and become a party to this Agreement as if such
Investor had executed such agreement at the Initial Closing. At the Subsequent
Subscription, the Company will deliver to the Investor instruments or
certificates evidencing the Securities being

                                        5

<PAGE>

purchased by the Investor at the Subsequent Subscription, each of which shall be
registered in such Investor's name as stated on Annex A-2 hereto with respect to
the Subsequent Subscription.

        (e) Notwithstanding the foregoing, no shares of Preferred Stock, and no
Warrants, shall be offered or sold after the Initial Closing to any Investor if,
in the opinion of the Company and its counsel, (i) such offer and sale would not
be exempt from the registration and prospectus delivery requirements of the
Securities Act and exempt from the registration or qualification requirements of
all applicable state securities laws, or (ii) such offers and sales would
detract from or adversely affect the availability and effectiveness of the
exemption from or compliance with such federal and state requirements relied
upon in respect of the offer and sale of Preferred Stock and Warrants to the
Investors at the Initial Closing.

        (f) [Intentionally omitted.]

        (g) Immediately prior to the Initial Closing, the Company shall prepare
Annex A with respect to the Investors purchasing Preferred Stock and Warrants at
the Initial Closing. Immediately prior to a Subsequent Subscription, the Company
shall prepare Annex A-2 with respect to the Investors subscribing for Preferred
Stock and Warrants at such Subsequent Subscription. Promptly after each
Subsequent Subscription, the Company shall amend Annex A-2 as appropriate.

     4. Register of Securities; Restrictions on Transfer of Securities; Removal
of Restrictions on Transfer of Securities.

        4.1 Register of Securities. The Company or its duly appointed agent
shall maintain a separate register for the shares of Preferred Stock, Warrants
and Common Stock, in which it shall register the issue and sale of all such
securities. All transfers of the Securities shall be recorded on the register
maintained by the Company or its agent, and the Company shall be entitled to
regard the registered holder of the Securities as the actual holder of the
Securities so registered until the Company or its agent is required to record a
transfer of such Securities on its register. Subject to Section 4.2(c) hereof,
the Company or its agent shall be required to record any such transfer when it
receives the Security to be transferred duly and properly endorsed by the
registered holder thereof or by its attorney duly authorized in writing.

        4.2 Restrictions on Transfer.

            (a) Each Investor understands and agrees that the Securities it will
be acquiring have not been registered under the Securities Act, and that
accordingly they will not be fully transferable except as permitted under
various exemptions contained in the Securities Act, or upon satisfaction of the
registration and prospectus delivery requirements of the Securities Act. Each
Investor acknowledges that it must bear the economic risk of its investment in
the Securities for an indefinite period

                                        6

<PAGE>

of time since they have not been registered under the Securities Act and
therefore cannot be sold unless they are subsequently registered or an exemption
from registration is available.

          (b) Each Investor hereby represents and warrants to the Company that:

              (i)   Such Investor is acquiring the Securities it has agreed to
purchase (and, if applicable, will acquire the Warrant Stock and Conversion
Stock) for investment purposes only, for its own account, and not as nominee or
agent for any other Person, and not with the view to, or for resale in
connection with, any distribution thereof within the meaning of the Securities
Act.

              (ii)  Such Investor knows of no public solicitation or
advertisement of an offer in connection with the Securities.

              (iii) Such Investor has carefully reviewed this Agreement and the
Offering Memorandum. Such Investor has had, during the course of the transaction
and prior to its purchase of the Preferred Stock and Warrants, the opportunity
to ask questions of and receive answers from the Company concerning the terms
and conditions of the offering and to obtain additional information necessary to
verify the accuracy of any information furnished to it or to which it had
access. Such Investor has received all information that it has requested
regarding the Company and believes that such information is sufficient to make
an informed decision with respect to the purchase of the Preferred Stock and
Warrants. Without limiting the generality of the foregoing, such Investor has
received a copy of (A) the 2001 Annual Report, (B) the Form 10-QSB, and (C) the
"Risk Factors" attached as Annex E hereto. The foregoing, however, does not
limit or modify the representations and warranties of the Company in Section 5
of this Agreement or the right of such Investor to rely thereon.

              (iv)  Such Investor is able to bear the economic risk of its
investment in the Preferred Stock and Warrants and has such knowledge and
experience in financial and business matters that it is capable of evaluating
the merits and risks of, and protecting its interests with respect to, its
investment in the Preferred Stock and Warrants. Such Investor is aware of the
risk involved in its investment in the Preferred Stock and Warrants and has
determined that such investment is suitable for it in light of its financial
circumstances and available investment opportunities.

              (v)   This Agreement, when executed and delivered by such
Investor, constitutes the legal, valid and binding obligations of such Investor
and are enforceable against such Investor in accordance with their terms, except
(i) as limited by applicable bankruptcy, insolvency, moratorium, reorganization
and other laws of general application affecting enforcement of creditors' rights
generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other

                                        7

<PAGE>

equitable remedies, and (iii) to the extent the indemnification provisions
contained in Section 9 of this Agreement may be limited by applicable federal or
state securities laws.

              (vi)   Such Investor is an "accredited investor" as that term is
defined in Rule 501 of Regulation D promulgated under the Securities Act.

              (vii)  Such Investor's jurisdiction of formation or incorporation
(if applicable) and principal place of business or its residency as set forth on
the signature page hereof or the annexes hereto by such Investor are accurate.

              (viii) The purchase by such Investor of the Preferred Stock and
Warrants hereunder does not violate or conflict with any law or regulation
applicable to such Investor.

              (ix)   No Person engaged by such Investor has, or will have, any
right or claim against the Company for any commission, fee or other compensation
as a finder or broker, or in any similar capacity.

          (c) Each Investor hereby further agrees with the Company as follows:

              (i)    Subject to Section 4.3 hereof, the instruments or
certificates evidencing the Securities it has agreed to purchase, and each
instrument or certificate issued in transfer thereof, will bear the following
legend:

     "The securities evidenced by this certificate have not been registered
     under the Securities Act of 1933, as amended, and have been taken for
     investment purposes only and not with a view to the distribution thereof
     and, except as stated in an agreement between the holder of this
     certificate, or its predecessor in interest, and the issuer corporation,
     such securities may not be sold or transferred unless there is an effective
     registration statement under such Act covering such securities or the
     issuer corporation receives an opinion, in form and content reasonably
     satisfactory to the issuer corporation, of counsel reasonably acceptable to
     the issuer corporation (which may be counsel for the issuer corporation)
     stating that such sale or transfer is exempt from the registration and
     prospectus delivery requirements of such Act."

              (ii)   The instruments or certificates representing such
Securities, and each instrument or certificate issued in transfer thereof, will
also bear any legend required under any applicable state securities law.

              (iii)  Each Investor covenants that in no event will it dispose of
any of the Securities (other than pursuant to Rule 144 or pursuant to a
registration statement filed with the Commission pursuant to the Securities Act)
unless

                                        8

<PAGE>

and until (i) such Investor shall have notified the Company of the proposed
disposition and shall have furnished the Company with a statement of the
circumstances surrounding the proposed disposition, and (ii) if reasonably
requested by the Company, such Investor shall have furnished the Company with an
opinion of its counsel, reasonably satisfactory in form and substance to the
Company, to the effect that (a) such disposition will not require registration
under the Securities Act or (b) appropriate action necessary for compliance with
the Securities Act and any applicable state, local or foreign law has been
taken. The restrictions on transfer imposed by this Section 4.2(c)(iii) shall
cease and terminate as to the Securities when: (i) such securities shall have
been effectively registered under the Securities Act and sold by the holder
thereof in accordance with such registration, or (ii) an opinion of the kind
described in the preceding sentence states that all future transfers of such
securities by the holder thereof would be exempt from registration under the
Securities Act.

                              (iv) Notwithstanding the provisions of paragraph
(iii), no such registration statement or opinion of counsel shall be necessary
for a transfer to an Affiliate of the Investor or by an Investor that is a
partnership or a limited liability company to a partner of such partnership or a
retired partner of such partnership who retires after the date hereof or a
member of such limited liability company or a retired member of such limited
liability company who retires after the date hereof, or to the estate of any
such partner, retired partner, member or retired member or the transfer by gift,
will or intestate succession of any partner or member to his or her spouse or to
the siblings, lineal descendants or ancestors of such partner or member or his
or her spouse, if the transferee agrees in writing to be subject to the terms
hereof to the same extent as if he or she were an original Investor hereunder.
For purposes of this Section 4.2(c)(iv) "Affiliate" shall mean any person or
entity that directly or indirectly through one or more intermediaries, controls,
is controlled by, or is under common control with the Investor.

                              (v) Such Investor consents to the Company's making
a notation on its records or giving instructions to any transfer agent of the
Common Stock, Warrants or Preferred Stock in order to implement the restrictions
on transfer of the Securities mentioned in this subsection (c).

                         (d)  Each Investor, or each Person executing this
Agreement on behalf of an Investor, further represents and warrants to the
Company that such Investor or other Person, as the case may be, has been duly
authorized to, and has, and as of the Initial Closing, and Subsequent
Subscription, if applicable, will have, full power and authority (including
corporate, if applicable) to, execute and deliver this Agreement on behalf of
such Investor, and to make the representations and warranties to the Company in
this Section 4 on behalf of such Investor, and to perform the obligations of
such Investor, if any, under this Agreement.

                    4.3  Removal of Transfer Restrictions. Any legend endorsed
on a certificate evidencing a Security pursuant to Section 4.2(c)(i) hereof and
the stop

                                       9

<PAGE>

transfer instructions and record notations with respect to such Security shall
be removed and the Company shall issue a certificate without such legend to the
holder of such Security (a) if such Security is registered under the Securities
Act, (b) if such holder provides the Company with an opinion, in form and
content reasonably satisfactory to the Company, of counsel (which may be counsel
for the Company) reasonably acceptable to the Company to the effect that a
public sale or transfer of such Security may be made without registration under
the Securities Act or (c) if such Security may be sold under Rule 144(k).

               5.   Representations and Warranties by and Covenants of the
Company. In order to induce each Investor to enter into this Agreement and to
purchase the Preferred Stock and Warrants, the Company hereby represents and
warrants to each Investor that, except as set forth on Annex F hereto:

                    5.1  Organization, Standing, etc. The Company is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware, and has all requisite corporate power and authority to
carry on its business as presently conducted and as proposed to be conducted, to
own and hold its properties and assets, to enter into this Agreement, to issue
the Securities and to carry out the provisions hereof and the terms of the
Certificate and the Securities.

                    5.2  Certificate of Incorporation and Bylaws. The copies of
the Certificate of Incorporation, as amended, and Bylaws of the Company which
have been delivered to (or made available for inspection by) the Investors prior
to the execution of this Agreement are true and complete and have not been
amended or repealed, except for the amendments to the Certificate of
Incorporation that will be accomplished by the filing of the Certificate with
the Delaware Secretary of State.

                    5.3  Subsidiaries. The Company has no Subsidiaries or
affiliated companies and does not otherwise own or control, directly or
indirectly, any equity interest in any corporation, association or business
entity.

                    5.4  Qualification. The Company is duly qualified as a
foreign corporation and in good standing in the State of California. The Company
is qualified to transact business and is in good standing in each jurisdiction
in which the conduct of its business or its ownership or leasing of property
requires such qualification, except where the failure to be so qualified or in
good standing would not have a Material Adverse Effect.

                    5.5  Capital Stock.

                        (a)   As of the Initial Closing Date, the authorized
capital stock of the Company will consist of (i) 5,000,000 shares of preferred
stock, par value $0.01 per share, 71,600 shares of which have been designated as
Series D Preferred Stock, 2,000,000 shares of which have been designated as
Series X Junior Participating

                                       10

<PAGE>

Preferred Stock, 55,000 shares of which have been designated as the Series E
Preferred Stock, 27,317 shares of which have been designated as the Series F
Preferred Stock, 35,000 of which have been designated as Series G Preferred
Stock, 30,000 of which have been designated as Series H Preferred Stock, and
100,000 of which have been designated as Series I Preferred Stock, and (ii)
60,000,000 shares of Common Stock; and the Company will have no authority to
issue any other capital stock. There are 1,344.01 shares of Series D Preferred
Stock issued and outstanding convertible into 35,840 shares of Common Stock
(assuming a stated conversion price of $3.75 per share) or into 244,365 shares
of Common Stock (assuming a conversion price of an average market price of $0.55
per share), no shares of Series X Junior Participating Preferred Stock issued
and outstanding, 20,875 shares of Series E Preferred Stock issued and
outstanding convertible into 1,670,000 shares of Common Stock, 26,420 shares of
Series F Preferred Stock issued and outstanding convertible into 704,533 shares
of Common Stock (assuming a stated conversion price of $3.75 per share) or into
4,803,636 shares of Common Stock (assuming a conversion price of an average
market price of $0.55 per share), 15,150 shares of Series G Preferred Stock
issued and outstanding convertible into 3,030,000 shares of Common Stock, 12,182
shares of Series H Preferred Stock issued and outstanding convertible into
1,624,266 shares of Common Stock, and no shares of Series I Preferred Stock
issued and outstanding, and, as of the Closing, before giving effect to the
transactions contemplated by this Agreement, 29,763,535 shares of Common Stock
are issued and outstanding, and all such outstanding shares of Series D
Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G
Preferred Stock, Series H Preferred Stock, and Common Stock have been duly
authorized and validly issued and are fully paid and nonassessable and were
issued in accordance with the registration or qualification provisions of the
Securities Act and any relevant state securities laws or pursuant to valid
exemptions therefrom.

                         (b)  Except as set forth in Annex F, no adjustment has
previously been made (or should have been made) nor will any adjustment be
required to be made as a result of the Company's issuance of the Preferred Stock
or any option, warrants or rights to purchase such shares (or the issuance of
Common Stock upon the conversion of the Preferred Stock) to the rate at which
shares of any capital stock or other securities of the Company are convertible
into or exercisable for shares of Common Stock (by reason of any "anti-dilution"
provisions or agreements or otherwise).

                         (c)  The Company has reserved a total of 10,165,203
shares of Common Stock remaining for issuance upon the exercise of stock options
or purchase rights granted or available for grant under the Stock Plans or under
other stock option agreements or warrants. Options or purchase rights to
purchase 1,938,950 shares of Common Stock are issued and outstanding under the
Stock Plans, and options or purchase rights to purchase 6,653,545 shares of
Common Stock are issued and outstanding pursuant to other stock options
agreements or warrants. A summary of outstanding options and warrants is
provided in Annex F.

                                       11

<PAGE>

                     (d) Except as contemplated by this Agreement or as
expressly provided in Annex F to this Agreement, the Company has no outstanding
subscription, option, warrant, right of first refusal, preemptive right, call,
contract, demand, commitment, convertible security or other instrument,
agreement or arrangement of any character or nature whatever under which the
Company is or may be obligated to issue Common Stock, preferred stock or other
Equity Security of any kind.

               5.6   Corporate Acts and Proceedings. The Company has, and as of
the Initial Closing will have, full corporate power and authority to execute and
deliver this Agreement and to perform its obligations hereunder and the
transactions contemplated hereby. All corporate acts and proceedings required
for the authorization, execution and delivery of this Agreement and the offer,
issuance and delivery of the Securities and the performance of this Agreement
and the terms of the Certificate have been lawfully and validly taken or will
have been so taken prior to the Initial Closing.

               5.7   Compliance with Other Instruments. The execution, delivery
and performance by the Company of this Agreement and the observance of the terms
of the Certificate (a) will not require from the Board or stockholders of the
Company any consent or approval that has not been validly and lawfully obtained,
(b) will not require the Company to obtain or effect any authorization, consent,
approval, license, exemption of or filing or registration with any Person,
except such as shall have been lawfully and validly obtained prior to the
Initial Closing, (c) will not cause the Company to violate or contravene, (i)
any provision of law, (ii) any rule or regulation of any Governmental Entity or
the National Association of Securities Dealers, (iii) any order, writ, judgment,
injunction, decree, determination or award binding upon the Company, or (iv) any
provision of the Certificate of Incorporation, as amended, or Bylaws of the
Company, (d) will not cause the Company to violate or be in conflict with,
result in a breach by the Company of or constitute (with or without notice or
lapse of time or both) a default by the Company under, any material agreement,
lease or instrument, commitment or arrangement to which the Company is a party
or by which the Company or any of its properties, assets or rights are bound or
affected, except where such violation, conflict, breach or default would not
have a Material Adverse Effect, and (e) will not result in the creation or
imposition of any lien or restriction, other than liens that may have been
created or suffered by the Investor and restrictions imposed by the Securities
Act, state securities laws or this Agreement. The Company is not in violation
of, or (with or without notice or lapse of time or both) in default under, any
term or provision of its Certificate of Incorporation, as amended, or Bylaws or,
in any material respect, of any indenture, loan or credit agreement, note
agreement, deed of trust, mortgage, security agreement or other agreement, lease
or other instrument, commitment or arrangement to which the Company is a party
or by which any of the Company's properties, assets or rights are bound or
affected, or, to the best of its knowledge, any provision of any federal or
state statute, rule or regulation applicable to the Company.

                                       12

<PAGE>

               5.8   Binding Obligations.

                     (a) This Agreement, when executed and delivered by the
Company, constitutes the legal, valid and binding obligations of the Company and
are enforceable against the Company in accordance with their terms, except (i)
as limited by applicable bankruptcy, insolvency, moratorium, reorganization and
other laws of general application affecting enforcement of creditors' rights
generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies, and (iii) to the
extent the indemnification provisions contained in Section 9 of this Agreement
may be limited by applicable federal or state securities laws.

                     (b) The Warrants are duly authorized and, when executed,
delivered and paid for in accordance with the terms of this Agreement, will be
free and clear of all liens and restrictions, other than liens that may have
been created or suffered by the Investor and restrictions imposed by the
Securities Act, state securities laws or this Agreement.

                     (c) The Preferred Stock is duly authorized and, when issued
and paid for in accordance with the terms of this Agreement, will be duly
authorized, validly issued and outstanding, fully paid and nonassessable and
free and clear of all liens and restrictions, other than liens that might have
been created or suffered by the Investors and restrictions imposed by the
Securities Act, state securities laws or this Agreement. The issuance of the
Preferred Stock will not be subject to any preemptive or similar rights that
have not been waived.

                     (d) The Conversion Stock and Warrant Stock have been duly
authorized and, when issued in accordance with the terms of the Certificate and
the Warrants, respectively, will be duly authorized, validly issued and
outstanding, fully paid and nonassessable and free and clear of all liens and
restrictions, other than liens that might have been created or suffered by the
Investors and restrictions imposed by the Securities Act, state securities laws
or this Agreement. The issuance of the Conversion Stock and Warrant Stock will
not be subject to any preemptive or similar rights that have not been waived.

               5.9   Securities Laws. Subject to the accuracy of the
representations and warranties contained in Section 4.2, the offer, issue and
sale of the Preferred Stock, Warrants, Conversion Stock and (assuming no
transfers of the Warrants and no change in applicable law between the date
hereof and the date of exercise of the Warrants) the Warrant Stock are and will
be exempt from the registration and prospectus delivery requirements of the
Securities Act, and are and will be exempt from qualification under the
California Securities Law and the state securities laws of the jurisdictions
where the Investors are resident.

               5.10 Financial Statements. Included in the Form 10-QSB are the
Company's unaudited balance sheet (the "Balance Sheet") as of September 30,
2002,

                                       13

<PAGE>

together with related notes thereto, (the "Balance Sheet Date"), and the
unaudited statement of operations for the nine-month period then ended, together
with related notes thereto. Included in the 2001 Annual Report are the Company's
audited balance sheets as of December 31, 2001 and 2000 and the audited
statements of operations, cash flow and shareholders' equity for the period then
ended, together with related notes, and the related opinions of Ernst & Young
LLP and Peterson & Co., independent certified public accountants. The foregoing
financial statements, together with related notes, (i) are complete and correct
in all material respects and are in accordance with the books and records of the
Company, (ii) present fairly the financial condition of the Company at the
Balance Sheet Date and other dates therein specified and the results of
operations and changes in financial position of the Company for the periods
therein specified, and (iii) have been prepared in accordance with generally
accepted accounting principles applied on a basis consistent with prior
accounting periods ("GAAP"), except that the unaudited financial statements are
subject to year-end audit adjustments and do not contain footnotes or statements
of shareholders' equity and cash flow.

               5.11  Changes. Since the Balance Sheet Date, except as disclosed
in the Form 10-QSB or on Annex F, there has been no event which would have a
Material Adverse Effect, nor any development reasonably likely to result in a
Material Adverse Effect, and the Company has not (a) mortgaged, pledged or
subjected to lien any of its material assets, tangible or intangible, (b) sold,
transferred or leased any of its assets, (c) cancelled or compromised any
material debt or claim, or waived or released any right, of material value, (d)
suffered any physical damage, destruction or loss (whether or not covered by
insurance) having a material effect, (e) declared or paid any dividends on or
made any other distributions with respect to, or purchased or redeemed, any of
its outstanding Equity Securities, except for accrued dividends on the Series D
Preferred Stock and the Series F Preferred Stock, or (f) suffered or experienced
any material adverse change or loss in its business other than its continuing
losses from operations.

               5.12  Material Agreements of the Company. The Company is not a
party to or otherwise bound by any written or oral agreement, instrument or
arrangement that is material to the Company except for those agreements listed
in Item 13 of the 2001 Annual Report or Item 6 of the Form-10QSB or as set forth
on Annex F hereto. The Company has furnished or made available to each Investor
true and complete copies of all such agreements and all other agreements,
instruments and other documents requested by any Investor or its authorized
representative.

               5.13  Litigation. There is no Action pending and, to the best
knowledge of the Company, there is no Action threatened against the Company or
its properties, assets or business. To the Company's best knowledge, the Company
is not in default with respect to any order, writ, judgment, injunction, decree,
determination or award of any court or of any Governmental Entity.

                                       14

<PAGE>

               5.14  Brokers or Finders. Except as set forth on Annex F hereto,
the Company has not incurred, and will not incur, directly or indirectly, as a
result of any action taken by the Company, any liability for brokerage or
finders' fees or agents' commissions or any similar charges in connection with
this Agreement. The Company agrees to indemnify and hold harmless the Investors
from any damages they incur as a result of any claims for such fees, commissions
or charges.

               5.15  Disclosure. The representations and warranties of the
Company contained herein, when read together with the annexes hereto and the
Form 10-QSB and the 2001 Annual Report do not contain any untrue statement of
material fact or omit to state a material fact necessary to make the statements
therein, in light of the circumstances under which they are made, not
misleading.

               5.16  Intellectual Property.

                     (a) (i) the Company has sufficient title to and ownership
of, free and clear of all liens, claims and encumbrances of any nature, all
patents, patent rights, patent applications, licenses, inventions, trademarks,
service marks, trade names, copyrights, confidential information, proprietary
rights and processes, know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or
procedures), and other intellectual property necessary for the conduct of its
business, except where the failure to have such title and ownership would not
have a Material Adverse Effect, and (ii) to the best of its knowledge, the use
by the Company of the foregoing does not conflict with or constitute an
infringement of the rights of others.

                     (b) The Company has not received any communications
alleging that it has violated, and has no knowledge that the Company has
violated, or by conducting its business, the Company will not, to the best of
its knowledge, violate any of the patents, patent rights, patent applications,
licenses, inventions, trademarks, service marks, trade names, copyrights,
confidential information, proprietary rights or processes, know-how (including
trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures), and other intellectual
property, of any other person.

               5.17  Retirement Obligations. Except as set forth on Annex F
hereto, the Company does not have any Employee Benefit Plan as defined in the
Employee Retirement Income Security Act of 1974, as amended, other than as
disclosed in the 2001 Annual Report.

               5.18  No Governmental Consent or Approval Required. Based in part
on the representations made by the Investors in Section 4 of this Agreement, no
authorization, consent, approval or other order of, declaration to, or
registration, qualification, designation or filing with, any federal, state or
local governmental agency or body is required by or from the Company for or in
connection with the valid and

                                       15

<PAGE>

lawful authorization, execution and delivery by the Company of this Agreement or
any other agreement entered into by the Company in connection with this
Agreement, and consummation of the transactions contemplated hereby or thereby,
or for or in connection with the valid and lawful authorization, issuance, sale
and delivery of the Preferred Stock and the Warrants or for or in connection
with the valid and lawful authorization, reservation, issuance, sale and
delivery of the Conversion Stock and the Warrant Stock, other than the filing of
the Certificate with the Delaware Secretary of State, the qualification (or
taking of such action as may be necessary to secure an exemption from
qualification, if available) of the offer and sale of the Preferred Stock and
Warrants under the California Securities Law and other applicable state or
federal securities laws, which filings and qualifications, if required, will be
accomplished in a timely manner so as to comply with such qualification or
exemption from qualification requirements.

               5.19  Registration. The Company's Common Stock is registered
pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and, except as set forth on Annex F hereto, the Company
has taken no action designed to, or likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act, nor has the Company
received any notification that the Securities and Exchange Commission is
contemplating terminating such registration.

               5.20  Reporting Status. Except as set forth on Annex F hereto,
the Company has filed in a timely manner all documents that the Company was
required to file under the Exchange Act during the 12 months preceding the date
of this Agreement and such documents complied in all material respects with the
Commission's requirements as of their respective filing dates, and the
information contained therein as of the date thereof did not contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein in light of the
circumstances under which they were made not misleading.

               5.21  Title to Property and Assets. The Company owns its property
and assets free and clear of all mortgages, liens, loans and encumbrances,
except such encumbrances and liens that arise in the ordinary course of business
or except where such encumbrances and liens are not reasonably likely to have a
Material Adverse Effect. With respect to the property and assets it leases, the
Company is in compliance in all material respects with such leases and, to the
best of its knowledge, holds a valid leasehold interest free of any liens,
claims or encumbrances.

               5.22  Environmental and Safety Laws. To the best of its
knowledge, the Company is not in violation in any material respect of any
applicable statute, law or regulation relating to the environment or
occupational health and safety, and to the best of its knowledge, no material
expenditures are or will be required in order to comply with any such existing
statute, law or regulation.

                                       16

<PAGE>

               5.23  Absence of Undisclosed Liabilities. The Company has no
material obligations or liabilities of any nature (matured or unmatured, fixed
or contingent) other than (i) those set forth or adequately provided for in the
Company's financial statements included in the Form 10-QSB and the 2001 Annual
Report or in the related Notes to Condensed Financial Statements included in the
Form 10-QSB, (ii) those incurred in the ordinary course of business and not
required to be set forth in the Balance Sheet under GAAP, (iii) those incurred
in the ordinary course of business since the Balance Sheet Date and not
reasonably likely to have a Material Adverse Effect and (iv) those incurred in
connection with the execution of this Agreement.

               5.24  Permits. The Company has all franchises, permits, licenses,
and any similar authority necessary for the conduct of its business as now being
conducted by it, the lack of which could have a Material Adverse Effect. The
Company is not in default in any material respect under any of such franchises,
permits, licenses, or other similar authority.

               5.25  Investment Company. The Company is not, after giving effect
to the offering and sale of the Preferred Stock and the Warrant Stock and the
application of the proceeds thereof will not be required to register as, an
"investment company" as such term is defined in the Investment Company Act of
1940, as amended.

               5.26  Market Manipulation. The Company has not taken and will not
take, any action designed to or that might reasonably be expected to cause or
result in stabilization or manipulation of the price of the Common Stock to
facilitate the sale or resale of the Securities, in violation of applicable law.

               5.27  Form S-2. The Company is eligible now and is aware of no
facts or circumstances that would make it ineligible to file a registration
statement on Form S-2 as of May 30, 2003.

               5.28  Registration Rights. Except as set forth on Annex F hereto,
no stockholder of the Company has any right (which has not been waived) to
require the Company to register the sale of any shares owned by such stockholder
under the Securities Act in the registration statement to be filed by the
Company on behalf of the Investors pursuant to Section 9.

               5.29  Acquisition. The Company is not in discussions and has not
reached any understanding, whether or not in writing, regarding potential terms
with respect to any transaction referenced in Regulation SX11-01(a), where the
business to be acquired would constitute a significant subsidiary as defined in
Rule 1-02(w) at the ten percent (10%) level.

               5.30  Independent Accountants. To the knowledge of the Company
after due inquiry, each of Ernst & Young LLP and Peterson & Co., who have
certified certain financial statements of the Company, are independent public
accountants

                                       17

<PAGE>

as required by the Securities Act and the Rules and Regulations of the
Commission thereunder.

               5.31  Significant Customers and Suppliers. No customer or
supplier that was significant to the Company during the period covered by the
financial statements referred to in Section 5.10 or that has been significant to
the Company thereafter, has terminated, materially reduced or threatened to
terminate or materially reduce its purchases from or provision of products or
services to the Company, as the case may be.

               5.32  Sarbanes-Oxley Act. The Company is not aware of any facts
or circumstances that would preclude it from being able to certify and file such
certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act of
2002, including complying with any Commission rules and regulations promulgated
pursuant thereto, in connection with the filing of the Company's next periodic
report to be filed under the Exchange Act.

          6.   Conditions of Parties' Obligations.

               6.1   Conditions of Investors' Obligations at the Closing. The
obligation of each Investor to purchase and pay for the Preferred Stock and
Warrants which it has agreed to purchase on the Initial Closing Date (or, if
applicable, the obligation of each Investor to subscribe for the Preferred Stock
and Warrants which it has agreed to subscribe for on the Subsequent Subscription
Date) is subject to the fulfillment prior to or on the Initial Closing Date (or,
if applicable, the Subsequent Subscription Date) of the following conditions,
any of which may be waived in whole or in part by such Investor; provided,
however, that after the Subsequent Subscription Date, if applicable, the
obligation of each Investor to purchase and pay for the Preferred Stock and
Warrants subscribed for in a Subsequent Subscription is subject only to the
fulfillment of the conditions set forth in clause (i) of Section 3(f):

                     (a) No Errors, etc. The representations and warranties of
the Company under this Agreement shall be true and correct on the Initial
Closing Date (or, if applicable, the Subsequent Subscription Date).

                     (b) Compliance with Agreement. The Company shall have
performed and complied with, in all material respects, all covenants,
agreements, obligations and conditions required by this Agreement to be
performed or complied with by it on or before the Initial Closing Date.

                     (c) Certificate of the Company. The Company shall have
delivered to each Investor a certificate of the Company dated the Initial
Closing Date (or, if applicable, the Subsequent Subscription Date), executed by
its President, certifying the satisfaction of the conditions specified in
subsections (a), (b), (d), (e), (g) and (h) of this Section 6.1.

                                       18

<PAGE>

                     (d) Certificate. The Certificate shall have been filed with
the Delaware Secretary of State.

                     (e) Qualification. All authorizations, approvals or
permits, if any, of any governmental authority or regulatory body of the United
States or of any state that are required from the Company in connection with the
lawful issuance and sale of the Preferred Stock and Warrants to the Investors
pursuant to this Agreement shall have been duly obtained and shall be effective
on and as of the Initial Closing.

                     (f) Opinion of Company Counsel. Each Investor shall have
received from Paul, Hastings, Janofsky & Walker LLP, counsel for the Company, an
opinion, dated as of the Initial Closing Date (or, if applicable, as of the
Subsequent Subscription Date), in the form attached hereto as Annex G.

                     (g) Approval of Holders of Other Series of Preferred Stock.
Each of (i) the holders of more than fifty percent of the outstanding Series D
Preferred Stock, (ii) the holders of more than seventy-five percent of the
outstanding Series E Preferred Stock, (iii) the holders of more than fifty
percent of the outstanding Series F Preferred Stock, (iv) the holders of more
than fifty percent of the outstanding Series G Preferred Stock, and (v) the
holders of more than fifty percent of the outstanding Series H Preferred Stock
shall have consented to the issuance of the Preferred Stock and the other
transactions contemplated hereby, and shall have waived their respective rights
of first refusal with respect to the issuance of the Preferred Stock, the
Warrants, the Warrant Stock and the Conversion Stock.

                     (h) Approval of Disinterested Board Members. A majority of
the disinterested members of the Board shall have approved this Agreement, the
Certificate and the transactions contemplated herein and therein.

                     (i) Proceedings and Documents. All corporate and other
proceedings in connection with the transactions contemplated at the Initial
Closing and all documents incident thereto shall be reasonably satisfactory in
form and substance to the Investors and their counsel, and the Investors shall
have received all such counterpart originals and certified or other copies of
such documents as they may reasonably request.

                     (j) Option Plan Increase. The Board shall have approved an
increase in the number of shares of Common Stock reserved for issuance and
available for grant upon the exercise of options to be granted under the
Company's 2002 Stock Option Plan to a total of 9,000,000 shares of Common Stock,
subject to approval by the stockholders of the Company at its next annual
meeting.

                     (k) Director Plan Increase. The Board shall have approved
an increase of 1,500,000 shares of Common Stock reserved for issuance and
available for grant upon the exercise of options to be granted under the
Company's 1996

                                       19

<PAGE>

Non-Employee Directors' Stock Option Plan, subject to approval by the
stockholders of the Company at its next annual meeting.

                     (l) Board Nominations. The Company shall nominate for
directors to stand for election at its next annual meeting, J. Thomas Parmeter,
Ph.D., Phillip Berman, M.D., Edward G. Cape, Ph.D., Edward J. Hartnett, Kerry L.
Kuhn, M.D., Philip J. Davis and George R. Walker.

                     (m) Lock-up Agreements. The Company shall have received
sufficient lock-up agreements from certain holders of the Company's outstanding
preferred stock, warrants and options pursuant to which such holders have agreed
not to convert or exercise such preferred stock, warrants or options into Common
Stock until the earlier to occur of (i) the Company having filed an amendment to
its Certificate of Incorporation increasing the number of authorized shares of
Common Stock of the Company to 120,000,000, or (ii) May 1, 2003, such that the
Company may issue the Series I Preferred Stock.

               6.2   Conditions of Company's Obligations. The Company's
obligation to issue and sell the Preferred Stock and Warrants to the Investors
on the Initial Closing Date and upon the Subsequent Subscription is subject to
the fulfillment prior to or at such date of (i) the conditions precedent
specified in paragraphs (d), (e), (g), (h) and (m) of Section 6.1 hereof, (ii)
the condition described in Section 3(c) hereof, if applicable, and (iii) the
representations and warranties of the Investors under this Agreement shall be
true and correct on the Initial Closing Date (or, if applicable, the Subsequent
Subscription Date).

          7.   [Intentionally omitted.]

          8.   [Intentionally omitted.]

          9.   Registration of Restricted Stock.

               9.1   Required Registration.

                     (a) Subject to the existing registration rights of the
holders of Series D Preferred Stock and Series F Preferred Stock, on or prior to
May 30, 2003 (the "Filing Deadline Date"), the Company shall use its best
efforts to prepare and file a registration statement under the Securities Act
(the "Registration Statement"), on a Form S-2 or other appropriate form selected
by the Company, covering the Restricted Stock and shall use its commercially
reasonable efforts to cause such registration statement to become effective
within one hundred twenty (120) days following the Initial Closing or final
Subsequent Subscription, as applicable, and to remain effective until the
earlier to occur of the date (i) the Restricted Stock covered thereby have been
sold, or (ii) by which all Restricted Stock covered thereby may be sold under
Rule 144, without volume limitations.

                                       20

<PAGE>

                     (b) Following the effectiveness of a registration statement
filed pursuant to this section, the Company may, at any time, suspend the
effectiveness of such registration for up to 45 days, as appropriate (a
"Suspension Period"), by giving notice to the Holders of Restricted Stock, if
the Company shall have determined that the Company may be required to disclose
any material corporate development which disclosure may have a Material Adverse
Effect. Notwithstanding the foregoing, no more than two Suspension Periods
(i.e., 90 days) may occur in immediate succession. The Company shall use its
best efforts to limit the duration and number of any Suspension Periods. The
Holders of Restricted Stock agree that, upon receipt of any notice from the
Company of a Suspension Period, the Holders of Restricted Stock shall forthwith
discontinue disposition of Restricted Stock covered by such registration
statement or prospectus until the Holders of Restricted Stock (i) are advised in
writing by the Company that the use of the applicable prospectus may be resumed,
(ii) have received copies of a supplemental or amended prospectus, if
applicable, and (iii) have received copies of any additional or supplemental
filings which are incorporated or deemed to be incorporated by reference into
such prospectus.

               9.2   Registration Procedures. When the Company effects the
registration of the Securities under the Securities Act pursuant to Section
9.1(a) hereof, the Company will, at its expense, as expeditiously as possible:

                     (a) In accordance with the Securities Act and the rules and
regulations of the Commission, prepare and file with the Commission a
registration statement with respect to such securities and use its commercially
reasonable efforts to cause such registration statement to become and remain
effective for the period described herein, and prepare and file with the
Commission such amendments to such registration statement and supplements to the
prospectus contained therein as may be necessary to keep such registration
statement effective for such period described in Section 9.1(a) and such
registration statement and prospectus accurate and complete for such period;

                     (b) Furnish to the Holders of securities participating in
such registration such reasonable number of copies of the registration
statement, preliminary prospectus, final prospectus and such other documents as
such Holders may reasonably request in order to facilitate the public offering
of such securities;

                     (c) Use its commercially reasonable efforts to register or
qualify the securities covered by such registration statement under such state
securities or blue sky laws of such jurisdictions as such participating Holders
may reasonably request within twenty (20) days following the original filing of
such registration statement, except that the Company shall not for any purpose
be required to execute a general consent to service of process or to qualify to
do business as a foreign corporation in any jurisdiction where it is not so
qualified;

                     (d) Notify the Holders participating in such registration,
promptly after it shall receive notice thereof, of the date and time when such
registration

                                       21

<PAGE>

statement and each post-effective amendment thereto has become effective or a
supplement to any prospectus forming a part of such registration statement has
been filed;

              (e) Notify such Holders promptly of any request by the Commission
for the amending or supplementing of such registration statement or prospectus
or for additional information;

              (f) Prepare and file with the Commission, promptly upon the
request of any such Holders, any amendments or supplements to such registration
statement or prospectus which, in the opinion of counsel for such Holders, is
required under the Securities Act or the rules and regulations thereunder in
connection with the distribution of the Restricted Stock by such Holders;

              (g) Prepare and promptly file with the Commission, and promptly
notify such Holders of the filing of, such amendments or supplements to such
registration statement or prospectus as may be necessary to correct any
statements or omissions if, at the time when a prospectus relating to such
securities is required to be delivered under the Securities Act, any event has
occurred as the result of which any such prospectus or any other prospectus as
then in effect would include an untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the
statements therein not misleading;

              (h) In case any of such Holders is required to deliver a
prospectus at a time when the prospectus then in circulation is not in
compliance with the Securities Act or the rules and regulations of the
Commission, prepare promptly upon request such amendments or supplements to such
registration statement and such prospectus as may be necessary in order for such
prospectus to comply with the requirements of the Securities Act and such rules
and regulations; and

              (i) Advise such Holders, promptly after it shall receive notice or
obtain knowledge thereof, of the issuance of any stop order by the Commission
suspending the effectiveness of such registration statement or the initiation or
threatening of any proceeding for that purpose and promptly use its best efforts
to prevent the issuance of any stop order or to obtain its withdrawal if such
stop order should be issued.

          9.3 Expenses. With respect to any registration effected pursuant to
Section 9.1 hereof, all fees, costs and expenses of and incidental to such
registration and the public offering in connection therewith shall be borne by
the Company; provided, however, that the Holders of Restricted Stock shall bear
their pro rata share of any underwriting discounts or commissions, if any.

          9.4 Delay in Filing of Registration Statement.

              (a) If the Registration Statement is not filed by the Company with
the Commission on or prior to the Filing Deadline Date, then for each day

                                       22

<PAGE>

following the Filing Deadline Date until, but excluded the date the Registration
Statement is filed with the Commission, the Company shall, for each such day,
pay the Investors, as liquidated damages and not as a penalty, an amount equal
to a weekly rate of 0.15% of the Required Payment; and for any such day, such
payment shall be made no later than the first business day of the calendar month
next succeeding the month in which such day occurs.

              (b) The parties agree that the sole damages payable for a
violation of the terms of this Section 9 with respect to which liquidated
damages are expressly provided shall be such liquidated damages. Nothing shall
preclude the Investor from pursuing or obtaining specific performance or other
equitable relief with respect to this Section 9.

              (c) The parties hereto agree that the liquidated damages provided
for in this Section 9 constitute a reasonable estimate of the damages that may
be incurred by the Investors by reason of the failure of the Registration
Statement to be filed in accordance with the provisions hereof.

          9.5 Indemnification.

              (a) The Company will indemnify and hold harmless each Holder of
shares of Restricted Stock which are included in a registration statement
pursuant to the provisions of Section 9 hereof and any underwriter (as defined
in the Securities Act) for such Holder, and any Person who controls such Holder
or such underwriter within the meaning of the Securities Act, and any officer,
director, employee, stockholder, agent, partner or affiliate of such Holder,
from and against, and will reimburse such Holder and each such underwriter,
controlling Person, officer, director, employee, stockholder, agent, partner and
affiliate with respect to, any and all claims, actions, demands, losses,
damages, liabilities, costs and expenses to which such Holder or any such
underwriter or controlling Person or any such officer, director, employee,
stockholder, agent, partner or affiliate may become subject under the Securities
Act or otherwise, insofar as such claims, actions, demands, losses, damages,
liabilities, costs or expenses arise out of or are based upon (i) any untrue
statement or alleged untrue statement of any material fact contained in such
registration statement, any prospectus contained therein or any amendment or
supplement thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, (ii) any breach of any
representation, warranty, agreement or covenant of the Company contained herein,
or (iii) any violation or alleged violation by the Company of the Securities
Act, the Exchange Act, any state securities law, or any rule or regulation
promulgated under the Securities Act, the Exchange Act, or any state securities
law; provided, however, that the Company will not be liable in any such case to
the extent that any such claim, action, demand, loss, damage, liability, cost or
expense is caused by an untrue statement or alleged untrue statement or omission
or alleged omission so made in conformity with information

                                       23

<PAGE>

furnished by such Holder, such underwriter or such controlling Person or such
officer, director, employee, stockholder, agent, partner or affiliate in writing
specifically for use in the preparation thereof.

              (b) Each Holder of shares of the Restricted Stock which are
included in a registration pursuant to the provisions of Section 9 hereof will
indemnify and hold harmless the Company, and any Person who controls the Company
within the meaning of the Securities Act, and any officer, director, employee,
agent, partner or affiliate of the Company, from and against, and will reimburse
the Company and such controlling Persons with respect to, any and all losses,
damages, liabilities, costs or expenses to which the Company or such controlling
Person may become subject under the Securities Act or otherwise, insofar as such
losses, damages, liabilities, costs or expenses are caused by any untrue or
alleged untrue statement of any material fact contained in such registration
statement, any prospectus contained therein or any amendment or supplement
thereto, or are caused by the omission or the alleged omission to state therein
a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances in which they were made, not
misleading, in each case to the extent, but only to the extent, that such untrue
statement or alleged untrue statement or omission or alleged omission was so
made in reliance upon and in conformity with written information furnished by
such Holder specifically for use in the preparation thereof. Notwithstanding the
foregoing, the liability of any Holder of Restricted Stock pursuant to this
subsection (b) shall be limited to an amount equal to the per share sale price
(less any underwriting discount and commissions) multiplied by the number of
shares of Restricted Stock sold by such Holder pursuant to the registration
statement which gives rise to such obligation to indemnify (less the aggregate
amount of any damages which such Holder has otherwise been required to pay in
respect of such losses, damages, liabilities, costs or expenses or any
substantially similar losses, damages, liabilities, costs or expenses arising
from the sale of such Restricted Stock).

              (c) Promptly after receipt by a party indemnified pursuant to the
provisions of paragraph (a) or (b) of this Section 9.5 of notice of the
commencement of any action involving the subject matter of the foregoing
indemnity provisions, such indemnified party will, if a claim thereof is to be
made against the indemnifying party pursuant to the provisions of paragraph (a)
or (b), notify the indemnifying party of the commencement thereof; but the
omission so to notify the indemnifying party will not relieve it from any
liability which it may have to an indemnified party otherwise than under this
Section 9.5 and shall not relieve the indemnifying party from liability under
this Section 9.5 unless such indemnifying party is prejudiced by such omission.
In case such action is brought against any indemnified party and it notifies the
indemnifying party of the commencement thereof, the indemnifying party shall
have the right to participate in, and, to the extent that it may wish, jointly
with any other indemnifying party similarly notified, to assume the defense
thereof, with counsel reasonably satisfactory to such indemnified party. After
notice from the indemnifying party to such indemnified party of its election so
to assume the

                                       24

<PAGE>

defense thereof, the indemnifying party will not be liable to such indemnified
party pursuant to the provisions of such paragraph (a) or (b) for any legal or
other expense subsequently incurred by such indemnified party in connection with
the defense thereof other than reasonable costs of investigation, unless an
indemnified party reasonably concludes that there may be defenses available to
it that are different from or additional to those available to the indemnifying
party; provided, however, that in such event, the indemnifying party shall bear
the fees and expenses of only one separate counsel for all indemnified parties.
No indemnifying party shall be liable to an indemnified party for any settlement
of any action or claim without the written consent of the indemnifying party. No
indemnifying party will consent to entry of any judgment or enter into any
settlement which does not include as an unconditional term thereof the giving by
the claimant or plaintiff to such indemnified party of a release from all
liability in respect to such claim or litigation.

              (d) If the indemnification provided for in subsection (a) or (b)
of this Section 9.5 is held by a court of competent jurisdiction to be
unavailable to a party to be indemnified with respect to any claims, actions,
demands, losses, damages, liabilities, costs or expenses referred to therein,
then each indemnifying party under any such subsection, in lieu of indemnifying
such indemnified party thereunder, hereby agrees to contribute to the amount
paid or payable by such indemnified party as a result of such claims, actions,
demands, losses, damages, liabilities, costs or expenses in such proportion as
is appropriate to reflect the relative fault of the indemnifying party on the
one hand and of the indemnified party on the other in connection with the
statements or omissions which resulted in such claims, actions, demands, losses,
damages, liabilities, costs or expenses, as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the
indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information
supplied by the indemnifying party or by the indemnified party and the parties'
relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. Notwithstanding the foregoing, the amount
any Holder of Restricted Stock shall be obligated to contribute pursuant to this
subsection (d) shall be limited to an amount equal to the per share sale price
(less any underwriting discount and commissions) multiplied by the number of
shares of Restricted Stock sold by such Holder pursuant to the registration
statement which gives rise to such obligation to contribute (less the aggregate
amount of any damages which such Holder has otherwise been required to pay in
respect of such claim, action, demand, loss, damage, liability, cost or expense
or any substantially similar claim, action, demand, loss, damage, liability,
cost or expense arising from the sale of such Restricted Stock). No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution hereunder from any person
who was not guilty of such fraudulent misrepresentation.

                                       25

<PAGE>

              9.6 Reporting Requirements Under the Exchange Act. The Company
shall timely file such information, documents and reports as the Commission may
require or prescribe under Section 13 of the Exchange Act. The Company
acknowledges and agrees that the purpose of the requirements contained in this
Section 9.6 is to enable the Holders of Restricted Stock to comply with the
current public information requirement contained in paragraph (c) of Rule 144
should any such Holder ever wish to dispose of any of the Restricted Stock
without registration under the Securities Act in reliance upon Rule 144 (or any
other similar exemptive provision).

              9.7 Stockholder Information. The Company may require each Holder
of Restricted Stock to furnish the Company such information with respect to such
Holder and the distribution of its Restricted Stock as the Company may from time
to time reasonably request in writing as shall be required by law or by the
Commission in connection therewith.

         10.  Miscellaneous.

              10.1 Waivers and Amendments.

                   (a) With the written consent of the Holders of a Majority of
the Preferred Stock then outstanding, the obligations of the Company and the
rights of the Holders of the Securities under this Agreement may be waived
(either generally or in a particular instance, either retroactively or
prospectively and either for a specified period of time or indefinitely), and
with the same consent the Company, when authorized by resolution of its Board,
may enter into a supplementary agreement for the purpose of changing in any
manner or eliminating any of the provisions of this Agreement or of any
supplemental agreement or modifying in any manner the rights hereunder of the
Holders of the Securities and the Company; provided, however, that no such
waiver or supplemental agreement shall reduce the aforesaid proportion of
Preferred Stock, the Holders of which are required to consent to any waiver or
supplemental agreement, without the consent of the Holders of all of the
Preferred Stock.

                   (b) Upon the effectuation of each such waiver, consent or
agreement of amendment or modification, the Company shall promptly give written
notice thereof to the Holders of the Preferred Stock who have not previously
consented thereto in writing.

              10.2 Effect of Waiver or Amendment. Each Investor acknowledges
that by operation of Section 10.1 hereof the Holders of a Majority of the
Preferred Stock then outstanding will, subject to the limitations contained in
such Section 10.1, have the right and power to diminish or eliminate certain
rights of such Investor under this Agreement.

              10.3 Rights of Holders Inter Se. Each Holder of Securities shall
have the absolute right to exercise or refrain from exercising any right or
rights which

                                       26

<PAGE>

such Holder may have by reason of this Agreement or any Security, including,
without limitation, the right to consent to the waiver of any obligation of the
Company under this Agreement and to enter into an agreement with the Company for
the purpose of modifying this Agreement or any agreement effecting any such
modification, and such Holder shall not incur any liability to any other Holder
or Holders of Securities with respect to exercising or refraining from
exercising any such right or rights.

              10.4 Exculpation Among Investors and Holders. Each Investor
acknowledges that it is not relying upon any other Investor, or any officer,
director, employee, stockholder, agent, partner or affiliate of any such other
Investor, in making its investment or decision to invest in the Company or in
monitoring such investment. Each Investor agrees that no Investor nor any
controlling Person, officer, director, stockholder, partner, agent or employee
of any Investor shall be liable for any action heretofore or hereafter taken or
omitted to be taken by any of them relating to or in connection with the Company
or the Securities, or both. Without limiting the generality of the foregoing, no
Investor (nor any of its affiliates, officers, directors, stockholders,
partners, agents or employees) or other Holder of any Security shall have any
obligation, liability or responsibility whatsoever for the accuracy,
completeness or fairness of any or all information about the Company or any
Subsidiary or their respective properties, business or financial and other
affairs, acquired by such Investor or Holder from the Company or the respective
officers, directors, employees, agents, representatives, counsel or auditors of
either, and in turn provided to another Investor or Holder, nor shall any such
Investor (or such other Person) have any obligation or responsibility whatsoever
to provide any such information to any other Investor (or such other Person) or
Holder or to continue to provide any such information if any information is
provided.

              10.5 Brokers or Finders. Each Investor represents and warrants to
the Company and each other Investor that, as a result of such Investor's
actions, except as set forth under Section 5.14 of Annex F, no Person has, or as
a result of the transaction as contemplated herein will have, any right or valid
claim against the Company or any other Investor for any commission, fee or other
compensation as a finder or broker, or in a similar capacity.

              10.6 Notices. All notices, requests, consents and other
communications required or permitted hereunder shall be in writing and shall be
given personally, by certified mail (return receipt requested, postage prepaid),
by air courier (with signed acknowledgment of receipt) or by facsimile
transmission (with confirmation of transmission):

        (a) If to any Holder of any of the Securities, addressed to such Holder
        at its address (or to its telecopier number) shown on his or its
        signature page hereto, or at such other address (or telecopier number)
        as such Holder may specify by written notice to the Company, or

                                       27

<PAGE>

        (b) If to the Company, addressed to it at 10655 Sorrento Valley Road,
        San Diego, California 92121 (or, if by telecopier, to (619) 558-6477) or
        at such other address (or telecopier number) as the Company may specify
        by written notice to the Investors,

and each such notice, request, consent and other communication shall for all
purposes of the Agreement be treated as being effective or having been given
upon receipt.

              10.7  Entire Agreement. This Agreement and the Warrants (including
the schedules, annexes and exhibits to each) constitute the entire agreement
among the parties with respect to the subject matter hereof and supercede all
prior and contemporaneous agreements, negotiations, discussions, arrangements or
understandings with respect thereto.

              10.8  Severability. Should any one or more of the provisions of
this Agreement or of any agreement entered into pursuant to this Agreement be
determined to be illegal or unenforceable, all other provisions of this
Agreement and of each other agreement entered into pursuant to this Agreement,
shall be given effect separately from the provision or provisions determined to
be illegal or unenforceable and shall not be affected thereby.

              10.9  Parties in Interest. All the terms and provisions of this
Agreement shall be binding upon and inure to the benefit of the respective
successors of the parties hereto. This Agreement shall not run to the benefit of
or be enforceable by any Person other than a party to this Agreement and his or
its successors and permitted assigns.

              10.10  Headings. The headings of the Sections and paragraphs of
this Agreement have been inserted for convenience of reference only and do not
constitute a part of this Agreement.

              10.11  Choice of Law. This Agreement shall be governed by, and
construed in accordance with, the substantive laws of the State of Delaware,
without regard to its principles of conflicts of laws.

              10.12  Expenses. The Company shall reimburse the Investors for the
reasonable and documented fees and expenses of one counsel, Wilson Sonsini
Goodrich & Rosati, in connection with the transaction, not to exceed $75,000.
The reasonable and documented fees and expenses of such counsel shall be paid by
the Company upon the Initial Closing and upon presentation of documentation in
reasonable detail supporting such fees and expenses. Except as provided in the
preceding sentence, each party to this Agreement shall bear its own costs and
expenses incurred with the negotiation and execution of this Agreement and the
performance of the transactions contemplated hereby.

                                       28

<PAGE>

              10.13 Counterparts. This Agreement may be executed in any number
of counterparts and by different parties hereto in separate counterparts, with
the same effect as if all parties had signed the same document. All such
counterparts shall be deemed an original, shall be construed together and shall
constitute one and the same instrument.

              10.14 Publicity. No party hereto shall originate any press release
or other public announcement, written or oral, relating to this Agreement, or to
performance hereunder or the existence of any arrangement among the parties
hereto without the prior approval of the other parties hereto which may be the
subject of such press release or announcement, except to the extent that such
press release or announcement is reasonably concluded by a party to be required
by applicable law. The Investors acknowledge that the Company will be required
to file a copy of this Agreement, and the other agreements and instruments
contemplated hereby, with the Commission and to describe these transactions in
its public filings. Except as provided in the immediately following sentence,
the Company shall not use the name of Johnson & Johnson Development Corporation
or any of its affiliates for advertising or promotional purposes without the
prior written consent of Johnson & Johnson Development Corporation. Johnson &
Johnson Development Corporation hereby consents to the Company's issuing a press
release substantially in the form attached hereto as Annex H.

              10.15 Same Terms and Price. The Company shall not sell or issue
any additional shares of Preferred Stock or Warrants after the Initial Closing
unless such sale or issuance is on the same terms and price as the Preferred
Stock and Warrants sold at the Initial Closing.

              10.16 Covenant to Issue Instruments or Certificates. Provided that
(A) the stockholders of the Company have approved an increase in the number of
shares of Common Stock reserved for issuance and available for grant upon the
exercise of options to be granted under the Company's 2002 Stock Option Plan to
a total of 9,000,000 shares of Common Stock, (B) the stockholders of the Company
have approved an increase of 1,500,000 shares of Common Stock reserved for
issuance and available for grant upon the exercise of options to be granted
under the Company's 1996 Non-Employee Directors' Stock Option Plan, and (C) the
stockholders of the Company have approved an increase in the number of
authorized shares of Common Stock of the Company to 120,000,000 shares, all on
or before April 30, 2003, the Company shall so amend such plans and Certificate
of Incorporation.

                            [Signature pages follow]

                                       29

<PAGE>

              IN WITNESS WHEREOF, the undersigned has caused this Agreement to
be duly executed as of the date first above written.

                                         PROTEIN POLYMER TECHNOLOGIES, INC.

                                         By /s/ J. Thomas Parmeter
                                            ------------------------------------
                                            J. Thomas Parmeter, President

                                       30

<PAGE>

                 [INVESTOR SIGNATURE PAGE TO PURCHASE AGREEMENT]

The foregoing Agreement is
hereby accepted as of the
date first above written.

______________________________________

By: __________________________________
    Name: ____________________________
    Title: ___________________________

Address for Notices:

    ________________________
    ________________________
    ________________________
    ________________________
    Attention:  ____________
    Telecopy: (___) ___-____

                                       31

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00055-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00055-of-00352.parquet"}]]